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Since the mid-2000s, public health and heath care-communities have become aware of the increased rates 
of traumatic brain injury (TBI) among active duty U.S. military personnel. In response to these public 
health concerns, Congress passed the Traumatic Brain Injury Act of 2008, which requires the Centers for 
Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), in consultation with 
the Department of Defense (DoD) and the Department of Veterans Affairs (VA), to determine how best to 
improve the collection and dissemination of information on the incidence and the prevalence of TBI 
among persons who sustained these injuries while in the military; and to make recommendations on the 
manner in which CDC, NIH, DoD, and VA can collaborate further on the development and improvement 
of TBI diagnostic tools and treatments. 
This report, Traumatic Brain Injury in the United States: Understanding the Public Health Problem 
among Current and Former Military Personnel, presents the major findings and recommendations of the 
members of the CDC, NIH, DoD, and VA Leadership Panel. These findings and recommendations are the 
product of a review of relevant scientific literature and a thorough examination of current TBI-related 
activities and programs conducted by the four agencies/departments. The report describes the public 
health importance of military service-related TBI, recommends how better to measure the magnitude of 
its medical and socio-economic impact, and suggests ways in which the four agencies/departments can 
collaborate further on the development and improvement of TBI-related diagnostic tools and treatments. 
Incorporating the recommendations of this report into public health policy and public health and clinical 
practice will help our nation to address the full impact and long-term consequences of TBI, will inform 
the development of more effective primary prevention strategies and policies, diagnostic tools and 
therapeutic interventions, and will allow for improved rehabilitation and reintegration of military and 
civilian TBI survivors in the United States. 
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Since the beginning of Operation Enduring Freedom (OEF) (Afghanistan) and Operation Iraqi Freedom 
(OIF), public health and health care-communities have become aware of the increased rates of traumatic 
brain injury (TBI) among active duty U.S. military personnel. Epidemiologic and clinical studies suggest 
that many of these military service-related injuries have serious long-term health and socioeconomic 
consequences. 
In response to these public health and medical concerns, Congress passed the Traumatic Brain Injury Act 
of 2008 (TBI Act of 2008), which requires the Centers for Disease Control and Prevention (CDC) and the 
National Institutes of Health (NIH), in consultation with the Department of Defense (DoD) and 
Department of Veterans Affairs (VA), to determine how best to improve the collection and dissemination 
of information on the incidence and prevalence of TBI among persons who were formerly in the military; 
and to make recommendations on the manner in which CDC, NIH, DoD, and VA can collaborate further 
on the development and improvement of TBI diagnostic tools and treatments. To that end, the CDC, NIH, 
DoD, and VA formed a Leadership Panel of experts with extensive experience in epidemiologic and 
clinical research, and in treating and managing TBI and its consequences. 
This report presents the major findings and recommendations of the Leadership Panel and a review of 
relevant scientific literature and a thorough examination of current TBI-related activities and programs 
conducted by the four agencies/departments. It describes the public health importance of military service-
related TBI, recommends how to measure the magnitude of the health and socioeconomic impact of TBI 
and suggests ways in which the four agencies/departments can collaborate further on the development and 
improvement of TBI diagnostic tools and treatments. 
Goals of the Report 
To respond to the mandate of the TBI Act of 2008 and to accomplish the goals of this report, CDC, NIH, 
DoD, and VA formed a Leadership Panel comprising representatives from each of these four 
agencies/departments. These persons were researchers and investigators with extensive experience in 
TBI-related epidemiologic and clinical research and in treating and providing rehabilitation for TBI 
survivors. To prepare their respective contributions to the report, members of the panel reviewed all 
current TBI-related activities and programs conducted by the four agencies/departments and relevant 
scientific literature. 
This report represents the culmination of the Leadership Panel’s deliberations and summarizes findings 
and recommendations. By sharing the results of this effort, CDC, NIH, DoD and VA aim to: 
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 Raise Awareness: Describe the public health importance of TBI among people currently or 
formerly in the military; 
 Improve Surveillance: Recommend how to better measure the magnitude and impact of this 
condition in this population and the country; and 
 Strengthen Collaboration: Suggest how the four agencies/departments can collaborate further 
on the development and improvement of TBI-related diagnostic and prognostic tools, treatment, 
management, and rehabilitation.  
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Background and Key Findings 
Traumatic brain injury (TBI) is one of the highest priorities in public health and medicine because of its 
magnitude, cost, and consequences (e.g., death and disability), and because it is often preventable. The 
Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control 
(NCIPC) estimates that each year approximately 1.7 million civilians in the United States sustain a TBI. 
Of these TBI injuries, which can occur alone or in combination with other injuries, about 1.36 million are 
treated and released from emergency departments (EDs), 275,000 are hospitalized, and 52,000 die. 
However, not all of these ED visits, hospitalizations and deaths are attributable to TBI, but might be due 
to other co-occurring injuries. These data suggest that the majority of TBIs (approximately 80%; 
Coronado, Thurman, Greenspan, and Weissman, 2009) are mild. These figures might not reflect the true 
incidence of TBI because they do not include people who are treated in physicians’ offices or outpatient 
facilities or those seeking medical care in non-civilian facilities (Faul, Xu, Wald, and Coronado, 2010). 
TBI among U.S. military personnel is a critically important health concern for veterans of the current 
Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF); these operations comprise 
several subordinate operations in Afghanistan, Horn of Africa, Trans Sahara, Philippines, Kyrgyzstan, as 
well as earlier theaters of military operations. According to a Defense and Veterans Brain Injury Center 
(DVBIC) analysis of surveillance data released by the Department of Defense (DoD), 33,149 U.S. 
military personnel were diagnosed with a TBI in 2011 alone. This number includes service members 
(SMs) from the Army, Navy, Marine Corps, Air Force, and from the active duty and reserve components 
of the National Guard. (U.S. Dept. of Defense: http://www.health.mil/Research/TBI_Numbers.aspx). The 
U.S. Department of Veterans Affairs (VA) estimates that of the 771,874 veterans who sought care from a 
VA Medical Center from the start of OEF in October 1, 2001 to December 31, 2011, a total of 59,218 
unique OEF and OIF veterans were evaluated or treated for a condition possibly related to a TBI (U.S. 
Dept. of Veterans Affairs, 2012: http://www.publichealth.va.gov/docs/epidemiology/healthcare-
utilization-report-fy2012-qtr1.pdf ). 
In response to these public health and medical concerns, Congress reauthorized the Traumatic Brain 
Injury (TBI) Act of 1996 with the passage of the Traumatic Brain Injury (TBI) Act of 2008 (P.L. 110-
206; U.S. GPO 2008), which requires CDC and the National Institutes of Health (NIH), in consultation 
with the Department of Defense and the Veteran’s Administration, to 
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 Determine how best to improve the collection and dissemination of information on the incidence 
(rate at which new cases of a condition occur in the population) and the prevalence (proportion of 
a population at any given time that is experiencing the effects of a condition) of TBI among 
persons who were formerly in the military; and 
 Make recommendations on the manner in which CDC, NIH, DoD, and VA can collaborate 
further on the development and improvement of TBI diagnostic tools and treatments. 
This report responds to these mandates. It was developed through a collaborative effort of a Leadership 
Panel made up of representatives from the four participating agencies/departments and was reviewed, 
cleared, and approved by the participating agencies/departments. Members of this Leadership Panel were 
clinicians, researchers, investigators, and science administrators with extensive experience in 
epidemiologic and clinical research and in treating and managing persons with TBI. 
Advances in TBI research in the past 30 years have created new opportunities for improved surveillance 
and for effective, acute and long-term medical care and rehabilitation; however, as detailed in this report, 
many important data and knowledge gaps persist. Several critical concerns and challenges related to the 
population of U.S. SMs who have sustained a TBI while in military service drive the recommendations 
included in this report. Although DoD and VA have made substantial progress in helping military 
personnel who have sustained a TBI, critical gaps remain in surveillance, epidemiology, clinical 
diagnosis, management, and rehabilitation, including a need to continue developing standard surveillance 
definitions, clinical definitions, and data collection methods as new knowledge and technology emerge. 
Some recent and current challenges include the following: 
 The annual rate of TBI among active duty personnel increased substantially from 2000 to 2011. A 
majority of the increases occurred from 2006 through 2008 (U.S. Department of Defense, 
unpublished data). 
 As is experienced in the general population, the actual rate of TBI among military personnel is 
potentially underestimated by existing TBI surveillance efforts. This is especially true for 
identification of personnel who have sustained a mild TBI. 
 The total burden of TBI among current and former military personnel, including medical costs, 
rehabilitation costs and lost productivity/income, is difficult to determine from existing data 
sources. 
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 Evidence on the effectiveness of acute and post-acute treatment is limited. Although some 
guidelines and recommendations exist for the acute and post-acute treatment and rehabilitation of 
persons sustaining a TBI, they are generally derived from expert consensus or case series studies, 
as evidence-based scientific knowledge is sparse or is less than optimal to justify the strongest 
clinical recommendations. 
 The influence of blast exposure on the risk for later developing neurodegenerative disorders is 
unknown. 
Recommendations 
The following general recommendations were developed in response to these concerns and to the 
questions posed in the TBI Act of 2008: 
 IMPROVE IDENTIFICATION:  Strengthen the identification of military service-related TBI 
among current military SMs and veterans, including those who do not seek care from the military 
or VA health-care systems. Emphasis will be given to improving data-collection initiatives and 
data sources to obtain a more comprehensive picture of the problem and impacts of TBI in this 
population. All four participating agencies should continue to foster and strengthen collaboration 
to this aim. 
 STANDARDIZE DEFINITIONS:  Use standard clinical and surveillance definitions and severity 
classification of TBI among U.S. military and civilian health-care providers and researchers to 
improve reporting. Update these definitions periodically as more precise, sensitive, and valid 
terms and definitions are available. 
 STANDARDIZE CLASSIFICATION:  Improve the coding and classification of TBI by working 
across agencies. All four participating agencies should continue to meet with professional, 
academic, health care, and coding organizations to discuss improvements in ICD-10-CM and TBI 
severity measures that can allow comparison of cases and outcomes. 
 ENHANCE DISSEMINATION:  Promote dissemination of information to non-VA facilities 
regarding TBI services available through the VA health-care system since 2007 including 
baseline screening and follow-up assessment and evaluation. 
 STRENGTHEN RESEARCH:  Continue research into the consequences of deployment-related 
TBI, including prospective investigation of the impact of single or multiple insults to the brain 
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and risk for cognitive decline or other health conditions later in life, which might occur among 
SMs and veterans. Share findings with civilian health-care providers. 
 FOLLOW EVIDENCE-BASED PREVENTION STRATEGIES:  Continue reducing risk factors, 
improving quality of protective equipment, and ensuring adherence to evidence-based strategies 
and guidelines. 
Evidence indicates that TBI in the U.S. population, including among those who served in the military, is a 
public health problem, the magnitude and impact of which are underestimated by current civilian and 
military surveillance systems. Much research is needed to determine the full magnitude of TBI, identify 
preventable and modifiable risk factors, develop and test strategies to reduce TBIs in civilian and military 
life, and improve health and social outcomes and quality of life for those who sustain these injuries. Such 
research will inform the development of more effective primary prevention strategies and policies, 
diagnostic tools, and therapeutic interventions and will allow for improved rehabilitation and recovery of 
TBI survivors.  
More details on each of the recommendations, including the rationale and potential benefits, can be found 
in this document. Imperative in planning for the future is recognizing that the public health and medical 
communities’ understanding of TBI is evolving, with many gaps in knowledge for both military and 
civilian populations. This report offers recommendations for future TBI-related epidemiologic and 




In response to public health concerns, Congress passed the TBI Act of 2008 (P.L. 110-206; U.S. 
Government Printing Office 2008), requiring the Secretary of the U.S. Department of Health and Human 
Services (DHHS), acting through the Directors of CDC and NIH, in consultation with the Secretary of 
Defense and the Secretary of Veterans Affairs, to submit a report on TBI to the relevant committees of 
Congress. It will contain the findings derived from an evaluation of activities and procedures that can be 
implemented by CDC to improve the collection and dissemination of compatible epidemiologic studies 
on the incidence and prevalence of TBI in persons who were formerly in the military. This report 
addresses that mandate and, as requested by Congress, also includes recommendations on the manner in 
which CDC, NIH, DoD, and the VA can collaborate further on the development and improvement of TBI 
diagnostic tools and treatments. 
Definition of TBI 
TBI was recently defined by a consensus panel of experts “as an alteration in brain function, or other 
evidence of brain pathology, caused by an external force” (Menon, Schwab, Wright, and Maas, 2010). 
TBI results from blunt or penetrating trauma to the head, or indirect acceleration and deceleration forces 
or blasts. These forces might temporarily or permanently disrupt the functioning of the brain. The extent 
and severity of a TBI after an initial mechanical event depends on many factors, including 1) the 
magnitude of direct or indirect forces applied to the head; 2) the direction of the force; and 3) the 
subsequent direction, duration and amplitude of angular accelerations to which the brain is subjected 
(Gaetz M. 2004). Other factors influencing the nature and severity of a TBI might include age, sex, body 
size and weight, comorbidities, alcohol use, genetics, and previous brain injuries, although the evidence 
on the specific positive or negative effects of each of these is limited. (Förstl, Haass, Hemmer, Meyer, 
and Halle., 2010; Coronado et al., 2009; Moppett, 2007; León-Carrión, Dominguez-Morales, Barroso y 
Martin, and Murillo-Cabezas, 2005; D'Ambrosio and Perucca, 2004; Roof , Duvdevani, and Stein, 1993; 
Pelligrino, Santizo, Baughman, and Wang, 1998).  The use of protective gear can reduce the occurrence 
and severity of brain injuries.  
The functional consequences of TBI range from transient, reversible alterations in brain function to 
profound disability or death. Recovery of neurologic functioning after TBI might or might not occur and 
varies in its time course from a few minutes to many years. More severe injuries require longer recovery 
periods. However, even in the case of mild TBI, a subset of persons develop post-concussion syndrome, a 
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syndrome characterized by headaches, depression, irritability, sleep disorder, poor concentration, and 
fatigue; various studies indicate that 38-80% of those with mild TBI may develop post-concussion 
syndrome (Hall, Hall, and Chapman, 2005). The effects of a prior TBI on the aging brain are not clear. 
Multiple severe concussive and sub-concussive injuries, like those reported in boxers who engaged in the 
sport for several years, are known to cause a delayed dementia syndrome (dementia pugilistica or chronic 
traumatic encephalopathy) (Zetterberg et al., 2006; Zetterberg et al., 2009; McKee et al., 2009; Gavett et 
al., 2011) that also might be evidenced by a Parkinson-like movement disorder. As described later in this 
report, case-controlled and cohort studies provide conflicting reports on whether a prior TBI is a risk 
factor for Alzheimer’s disease (Van Den Heuvel C, Thornton, and Vink, 2007; Fleminger S, Oliver, 
Lovestone, Rabe-Hesketh, and Giora, 2003). Overall, the scope, complexity, and heterogeneity of TBI 
present challenges for developing precise, sensitive, and accurate diagnostic and prognostic tools and 
effective medical and other health-related (e.g., rehabilitation) interventions.
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II. Pathophysiology and Mechanisms 
TBIs can be classified in many ways (Saatman et al., 2008). For the purposes of this report, TBI is 
classified as follows: by physical cause, by functional severity, or by the physical changes associated with 
TBI. The initial impact to the brain in TBI might result in one or more direct effects. For example, a blow 
to the head from a fall can cause bleeding and bruising of the brain. The result of the initial impact often 
gives rise to a number  of secondary effects that further worsen the severity of the injury.  
Brain injuries also can be characterized as focal (localized) or diffuse (widespread); the localization of 
injury depends primarily on the initial mechanical trauma. The features of TBI include bleeding around 
the brain or between the brain and the skull, bruising to the brain that is either localized or diffuse. Other 
features include decreased blood flow to the brain or swelling of brain tissue, which can contribute to 
complex secondary outcomes. TBI is sometimes also discussed in the context of primary or immediate 
injury versus secondary or delayed injury. The physical cause of primary injury can be classified as 
closed, penetrating, or blast. Classification based on patterns and types of injury is essential for therapy 
development but is also challenging (Marshall et al., 1992). 
Primary Injury 
Primary injury occurs immediately and as direct result of mechanical trauma. Depending on the injury 
mechanism and severity, the initial event might cause direct or primary mechanical alterations of the brain 
tissue (e.g., widespread damage to the axons that provide support and structure to the brain, laceration of 
the brain, bleeding around the brain or between the brain and the skull, and bruising to the brain). 
Autopsy studies following fatal TBI have reported large variability in primary and secondary injuries 
(Adams, Mitchell, Graham, and Doyle, 1977; Bigler and Maxwell, 2011). These types of injuries can 
occur alone or in combination and are often accompanied by other traumatic injuries to multiple organs or 
body parts. 
Secondary Injury 
Secondary brain injuries arise from complications initiated by the primary injury itself and via other 
mechanisms, including inflammation, cell receptor mediated dysfunction, free radical and oxidative 
damage, and calcium or other ion-mediated cell damage (Graham, Gennarelli, and McIntosh, 2002). 
Primary mechanical changes are generally followed by several biologic processes that occur in the 
minutes to days following TBI (Scalea, 2005; Gennarelli and Graham, 2005; Granacher RP, 2007), 
resulting in secondary brain injuries that can include the build-up of excess fluid in the brain that gives 
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rise to elevated intracranial pressure (Granacher, 2007; Porth, 2007; Sullivan et al, 2000; Sauaia et al., 
1995). In turn, these secondary processes modulate gene expression and/or protein regulation that lead 
either to cell death or repair (Graham et al., 2002; Luukinen et al, 2005). Researchers have pursued many 
of these processes as potential targets for therapies that might limit the extent and severity of injury after 
TBI. 
As in other tissue injuries, an inflammatory reaction to TBI also can occur. Inflammation is involved in 
the repair of brain tissue after injury, but it can also contribute to secondary brain damage. Secondary 
injury also might result from other systemic events related to multiple injuries in other organs or body 
parts; for example, an overall drop in blood pressure might reduce the blood flow to the brain, which 
contributes to the severity and extent of the initial injury (Scalea 2005). Alterations in the regulation of 
brain blood flow also occur after TBI. Focal constriction of major brain arteries has recently been 
described after blast TBI (Bell et al., 2009). Such large artery vasospasm confined to a small area is 
considered unusual after non-blast TBI, although it also might be an underappreciated problem (Shahlaie, 
Boggan, Latchaw, Ji, and Muizelaar, 2009). Because the brain is enclosed in the non-expandable skull, 
brain swelling and hemorrhage added to the intracranial compartment can lead to distortion and 
compression of brain structures and to raised intracranial pressure (ICP). Elevated ICP after TBI can 
impede blood flow and thereby cause widespread lack of oxygen to the brain that can result in brain death 
(Wijdicks, 1995). 
Focal and Diffuse Injury 
TBI can present as a focal (localized) or diffuse (widespread) injury. Some patients may exhibit both 
focal and diffuse injuries. A focal injury results when bleeding, bruising or a penetrating injury is isolated 
to a portion of the brain. Focal injury causes neurologic deficits that are related to the functions that take 
place in the damaged region of the brain. Diffuse brain injury to the axons that connect brain structures is 
also common, as these “brain wires” provide the major mechanical support to brain tissue and are subject 
to damaging strain forces upon impact or rapid acceleration/deceleration. Though the neuropathology of 
blast injury in service members has not been studied systematically, animal studies demonstrate diffuse 
brain injury after blast trauma (Cernak, 2005). Diffuse brain injury also might occur from rapid 
acceleration and deceleration forces to the head, a common factor in motor vehicle crashes. The 
neurologic deficits caused by diffuse brain injury also can affect overall brain function.  
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Closed: Impact and Acceleration/Deceleration 
Impact of the head against another object (Adams, Victor, and Ropper, 1997) can cause focal brain injury 
under the skull at the site of impact and sometimes at a site on the opposite side of the head, called 
contrecoup. These focal impact injuries, termed contusions, are prone to bleeding. Bleeding also can 
occur into other intracranial spaces, including the space that contains the cerebrospinal fluid that 
surrounds the brain (known as traumatic subarachnoid hemorrhage) and the space underneath the thick 
leathery dura that is attached to the undersurface of the skull (known as traumatic subdural hematoma). 
When a skull fracture disrupts arteries that lie over the dura, bleeding might occur between the dura and 
the skull (epidural hematomas). Intracranial bleeding can lead to death or permanent disability and might 
worsen over variable periods (minutes to days) post-TBI. Because the skull is a rigid structure and not 
expandable, the volume of blood that can be accommodated is limited before pressure inside the skull 
begins to rise and distortion of brain structures occurs. Evacuation of posttraumatic intracranial blood is 
one of the most common neurosurgical interventions after TBI (Bullock et al 2006). 
The most common form of TBI is caused by a combination of impact and acceleration/deceleration 
forces, such as what occurs in high-speed motor vehicle crashes (Kotapka et al., 1991; Adams, Graham, 
Murray, and Scott, 1982). Acceleration/deceleration creates forces that can damage the brain even if no 
actual impact of the head against another object occurs, (although the latter is unusual and requires much 
higher forces; (Duhaime, 2006]). Impact combined with acceleration/deceleration injury causes shearing 
of the connecting fibers in the brain. After death,  in brains viewed under a microscope, shearing is visible 
as disruption and focal swelling of the nerve axons. Visualizing shear injury on standard neuroimaging is 
difficult (Hammond and Wasserman, 2002; Gold and Lipton, 2008). New advanced magnetic resonance 
imaging (MRI) techniques, might improve imaging of brain lesions, especially those in the mild spectrum 
and help in the diagnosis of brain injuries. Because these technologies are continuously evolving, they 
must be refined and validated. (Kirov et al., 2013) 
Penetrating Injury 
Penetrating TBI occurs when an object enters the brain, whether a bullet, shrapnel, knife, bone fragment, 
or other material. Penetrating injury is focal because of the mechanical disruption of specific brain regions 
along the track of the object. However, injury also can occur further away from the object’s track because 
of the transmission of kinetic energy from a high-speed projectile to the brain. Penetrating head injury 
causes a greater risk of posttraumatic seizures and epilepsy than closed head injury (Temkin, 2009). 
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Blast Injury 
Blast injury is the result of pressure waves interacting with the body following exposure to a high-order 
explosion, that is, an explosive event where the blast pressure front moves rapidly, shattering objects in its 
path. Though studied in the past, blast injury is subject to more intensive scrutiny since the onset of 
Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF). The blast environment presents 
a high risk for penetrating TBI related to shrapnel and forces that cause rapid head movement or impact 
against other objects, resulting in shear injury or contusion, respectively. Current evidence from animal 
studies suggests that brain injury can occur as a result of blast pressure waves–even if the wave is directed 
at the chest (Courtney and Courtney, 2009). Whether lung injury itself contributes to brain injury, or 
whether the structures of the chest participate in transmitting the blast forces to the brain, is not 
definitively known. For this reason, body armor might offer some brain protection. Although helmets 
protect the brain from penetrating injury, skull fracture, and contusion, they might not dampen a blast 
wave and injury may still occur.  
The details of how a blast wave causes brain damage are still poorly defined; standard neuroimaging is 
generally unrevealing. Major questions remain, including the following: What levels of a single blast 
intensity or distance from the blast are tolerated without permanent injury? Do repeated prior exposures to 
blast increase vulnerability? Are any longer term-consequences to blast exposure evident? A major gap in 
understanding is caused by the lack of information about the pathology of blast injury in humans, which 
is related to limited research on post-mortem brains. In addition, because of the combination of different 
mechanisms of TBI in the blast area, differentiating the primary blast pathology from those caused by 
blunt injury, penetrating objects, or shear injury is difficult. Moreover, biological processes that occur as a 
result of primary and secondary injuries of any external cause, including blast-related TBIs, are not well 
understood. 
Preliminary data suggest that major differences in symptom etiology and pathophysiology are evident 
between SMs with blast-related closed TBI and non-blast closed TBI (Moore et al., 2009; Hoffer, 
Donaldson, Gottshall, Balaban, and Balough, 2009; Hoffer et al 2010). Scientists have used a brain-
imaging technique called diffuse tensor imaging (DTI) to identify the effects of different injury 
mechanisms. A DTI study comparing blast and non-blast injury determined that blast injuries resulted in 
more diffuse damage than non-blast injuries. Blast injuries, but not non-blast injuries, were associated 
with changes in blood flow or structural brain abnormalities (Moore, 2009; Huang et al., 2009).
 
In 
Landstuhl Regional Medical Center, an MRI study of military personnel with a mild TBI diagnosis after 
exposure to blast demonstrated subtle abnormalities on diffusion imaging in a subset of patients (18/63) 
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(MacDonald et al.,2011). Single photon emission CT (SPECT) and positron emission tomography (PET) 
both demonstrate hypoperfusion (decreased blood flow through an organ) of the frontal lobes, possibly 
explaining many of the cognitive and behavioral symptoms associated with mild TBI (Nakayama, 
Okumura, Shinoda, Nakashima, and Iwama, 2006; Gowda et al., 2006). 
Research Relevant to Active Duty Personnel and Veterans 
Research collaborations among the four participating agencies (CDC, NIH, DoD, VA) is a fundamental 
starting point to solving the various problems associated with TBI. Current research is the foundation on 
which further endeavors can build consensus and effort. 
Several clinical trials have attempted to slow secondary processes that contribute to additional damage 
following TBI. Despite potent neuroprotection of certain chemical compounds in rodent models of head 
injury , no strategy has so far succeeded in humans. Scientists continue to attempt developing an effective 
neuroprotective treatment to be administered within hours of the initial trauma to improve patient 
outcome, including a recently launched multi-center study of progesterone, a treatment modality that 
demonstrated promise in animal models (U.S. National Institutes of Health, 2012). NIH also funds 
research examining brain recovery after injury. In a collaborative effort, NIH and DoD have established 
the Federal Interagency TBI Research (FITBIR) Informatics database to facilitate comparison among 
studies and enhance comparative effectiveness research in TBI. 
Studies have found that approximately one-third of SMs with mild TBI also have PTSD (Hoge et al, 
2008; Brenner et al, 2009).  Because of the overlap in symptoms and this common co-occurrence of 
PTSD and TBI in SMs, studies related to hormonal differences and imaging findings between PTSD and 
TBI are ongoing. In the interim, several programs, including those at Fort Campbell, Landstuhl Regional 
Medical Center, Waco Veterans Affairs Medical Center (VAMC), National Intrepid Center of Excellence 
in Bethesda, and Cincinnati VAMC have developed programs to treat both mild TBI and PTSD 
simultaneously. 
 
Without published reports of blast neuropathology in soldiers, scientists are unable to compare what they 
find in animal models to what is actually happening in persons who have suffered from TBI. To help 
build pathology data, DoD and others have begun postmortem tissue banks. DoD has developed the TBI 
Brain Bank through the Armed Forces Institute of Pathology (AFIP), with support from DVBIC, where 
appropriate patient data and brain specimens of deceased SMs can be archived for further clinical and 
pathological studies. Officially begun in 2009, this DoD program has the potential to be used for the 
congressionally mandated 15-year longitudinal study of returnees and veterans of OIF and OEF. Study 
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participants will be invited to consider post-mortem donation of their brains to the DoD TBI Brain Bank 
as a secondary study arm. In comparison with severe TBI, much less is known about the pathoanatomical 
or pathophysiological alterations that are produced by mild or concussive injuries, because only in rare 
cases are these injuries fatal and standard neuroimaging is unrevealing. There may be other opportunities 
for sharing brain bank resources across agencies to further advance the state of the science. 
Research Programs Related to Active Duty Personnel 
In the last decade, much work was done to elucidate problems associated with military service-related 
TBI. A primary focus has been on understanding blast injury (Lee et al., 2011; MacDonald et al., 2011) 
primarily because of the high rate of TBI and blast-related concussion events resulting from combat 
operations and the limited knowledge about the blast effects on the central nervous system. These blast-
related injuries directly affect the health and safety of individual SMs and thereby also affect the level of 
unit readiness and troop retention (Defense and Veterans Brain Injury Center [DVBIC], 2012: 
http://www.dvbic.org/about/tbi-military). In response, on July 5, 2006, DoD issued DoD Directive 
6025.21E "Medical Research for Prevention, Mitigation, and Treatment of Blast Injuries" in compliance 
with Section 256 of Public Law 109–163 (U.S. Dept. of Defense, 2006).  
This DoD Directive formally established the DoD Blast Injury Research Program that coordinates and 
manages the medical-research activities and programs of DoD relating to the prevention, mitigation, and 
treatment of blast injuries. Through this program, increased funding has been made available for projects 
that will help identify effects of blast on the brain, mitigate risks, and develop diagnostics and 
interventions to mitigate brain damage and promote recovery. Through a series of delegations of 
authority, the United States Army Medical Research and Materiel Command (USAMRMC), a 
subordinate command of the U.S. Army Medical Command (USAMEDCOM), was selected to carry out 
the Program's day-to-day coordination and management activities because of its unique position and 
expertise as the Army's total life cycle medical research, development, acquisition, procurement, and 
logistical support command  (U.S. Dept. of Defense, 2011: 
https://blastinjuryresearch.amedd.army.mil/index.cfm?f=application.introduction). Under this research 
program, studies using advanced imaging techniques have demonstrated that structural pathology 
associated with persistent symptoms in those with blast-related TBI might be evident (Peskind et al., 
2011; Matthews et al., 2011). The Blast Injury Research Program is focused on filling gaps in the blast-
injury knowledge base. Key research topics by program area, for example, include the following: 
 Acute Treatment: In this area, DoD is working to 
o Develop diagnostics and neuroprotective drugs for TBI. 
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o Develop hemorrhage control and blood products. 
o Develop treatments for psychological trauma. 
 Reset (a term used in the military to describe a concept that extends beyond rehabilitation to 
include all activities necessary to return injured SMs to duty or to productive civilian life). In this 
area, DoD is working to 
o Advance tissue engineering and prosthetics. 
o Improve recovery of physical and mental functioning. 
o Develop return-to-duty standards. 
 
Studies examining the effects of blast injuries are ongoing. Preliminary data suggest that major 
differences exist in pathophysiology between service members with blast-related TBI and blunt TBI 
(Moore et al., 2009). In a DTI study comparing blast and blunt injury, blast injuries revealed a more 
diffuse pattern than blunt injuries (Moore, 2009; Huang et al., 2009). Blast injuries were associated with 
abnormalities in the apparent diffusion coefficient, a measure of the movement of water through cell 
membranes and other parts of the brain, not seen in blunt injuries.  
The Breacher Injury Study, conducted by the Defense Advanced Research Projects Agency and the 
Office of Naval Research (Applied Research Associates, 2009; Combating Terrorism Technical Support 
Office, 2008) examines the physiological effects or the risks of cognitive impairment as a result of 
repeated, low-level blast exposures. This is the first prospective study with humans to quantify blast-
related TBIs. Aspects of this study were conducted in Breacher trainees (personnel trained to use 
explosives to gain rapid entry into a facility) from the U.S. Marine Corps’ Weapons Training Battalion 
Dynamic Entry School. The study determined that the trainees did not demonstrate any negative effects 
due to the exposure. However, the trainers who had greater accumulated exposure over time experienced 
subtle, reversible cognitive changes after training practices. As a result, the Technical Support Working 
Group (TSWG) recommended various mitigation measures. The personnel-borne data-acquisition 
systems used in this study were miniaturized, enabling instrumentation of each Breacher during breaching 
events. Results of this study are being used to direct future research into protective gear for Breachers 
(Applied Research Associates, 2009; Combating Terrorism Technical Support Office, 2008), and findings 
can be extrapolated to other branches of the U.S. military to prevent injuries. Understanding the effects of 
the levels of exposure to blasts on the brain might help to improve surveillance by allowing a better 
diagnosis and case ascertainment, especially in patients with mild TBIs. Findings from efforts like the 
Breacher Injury Study might result in better follow up, rehabilitation, and provision of services. 
 10 
Research Programs Related to Veterans 
VA has undertaken various activities to understand better the impact of TBI among veterans. Some of the 
most persistent and disabling consequences include the ability to select and retain goal-relevant 
information and to use it for decision-making and goal management in daily life (Ry, Cullen, and Bayley, 
2010)—skills that persons without TBI take for granted. Common symptoms of these deficits are being 
easily distracted, and difficulty with concentration, organization, prioritization, and planning. The VA 
sponsored two special issues of the Journal of Rehabilitation Research and Development that focused on 
TBI and polytrauma in the veteran population (Department of Veterans Affairs [VA], 2007 & 2009). 
PTSD, auditory, visual, motor impairment, balance, and other clinical concerns were featured, along with 
polytrauma, rehabilitation, telemedicine for TBI, and research opportunities. More recently, investigators 
identified a strong relationship between PTSD and post-concussive syndrome (PCS) and determined that 
evaluation of both factors is important in clinical management (Benge, Pastorek, and Thornton, 2009). 
VA researchers are focused on a number of veteran-centric TBI research projects that can be searched 
through the NIH RePORTER system at http://projectreporter.nih.gov/  (enter “TBI” in the Text Search 
field and select VA in the Agency/Institute/Center field and submit query). Selected relevant publications 
include the following: 
 Evaluation of DTI, Magneto Encephalography (MEG), and Computed Tomography (CT) scans to 
detect mild TBI indicated that MEG might be more sensitive than DTI and CT scans (Huang et 
al., 2009). 
 A study on visual impairment and dysfunction in SM TBI cases suggests that combat troops 
exposed to a blast with a mild TBI are at increased risk for visual dysfunction such as blurred 
vision, difficulty reading or squinting (Brahm et al., 2009). 
 A randomized trial comparing cognitive and functional rehabilitation approaches documented 
better short-term cognitive performance among participants receiving cognitive treatment 
(Vanderploeg et al., 2008). 
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III. Diagnosis 
Screening for symptoms possibly associated with TBI involves a quick evaluation of possible exposure to 
an injury event to determine if an alteration of consciousness (AOC) was evident, if it was associated with 
the event, or if the event resulted in any neurologic changes or symptoms (Department of Defense, 2007). 
The majority of cases of TBI in the U.S. military are mild TBI and although mild TBIs are often difficult 
to detect, TBI in persons with multiple trauma—major injuries to the chest, abdomen, pelvis, or 
extremities—also might be overlooked as other more life-threatening injuries are addressed. Positive TBI 
screening results should be followed up with a comprehensive evaluation from which a diagnosis is made. 
This comprehensive TBI evaluation should include identifying the external cause of the patient’s injury, 
assessment for neurobehavioral symptoms, a targeted physical examination, and a follow-up treatment 
plan. 
Pre-Deployment Neurocognitive Baseline Testing 
On May 28, 2008, the Assistant Secretary of Defense for Health Affairs (ASD/HA) issued an interim 
policy letter calling for the Services to “begin implementing baseline pre-deployment neurocognitive 
assessments for deploying SMs.” The DVBIC was designated the Office of Responsibility for this DoD 
program known as the Neurocognitive Assessment Tool (NCAT) Program. ASD/HA selected the 
Automated Neuro-psychological Assessment Metric (ANAM) as the neurocognitive assessment tool; this 
instrument allows acquiring a baseline assessment of cognitive performance areas most likely affected by 
mild TBI, including attention, judgment, and memory.  
Baseline pre-deployment neurocognitive assessments are administered to all SMs 4–6 months before 
deployment and sequenced with the pre-deployment training plan (PTP). This sequencing allows the 
respective commander and command surgeon the timely opportunity to evaluate SMs who might screen 
positive. This window also provides the greatest opportunity for the unit’s medical assets to evaluate, re-
evaluate, refer, and begin a medical regimen based upon local treatment protocols. This timeliness allows 
commanders and medical treatment facilities the opportunity to better manage manpower resources to 
meet mission requirements.  
The goal of this pre-deployment testing is to have the capability to compare assessment results before and 
after an SM is exposed to a blast event, to improve the detection and treatment of mild TBI. This practice 
will ultimately affect return-to-duty decisions. From June 2007 through March 2012, 743,309 SMs 
(35.3% of all who deployed during that period) had completed pre-deployment baseline cognitive testing. 
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The NCAT is used in conjunction with clinical practice guidelines for managing concussion in deployed 
and non-deployed settings.  
The pre-deployment testing program also includes a self-report historical questionnaire screen to 
determine if TBI or concussion occurred in the past. If an affirmative answer is given in the initial 
question, additional information is sought regarding loss of consciousness or alteration in consciousness 
and post-concussive symptoms immediately following the injury and experienced in the 2-year period 
before testing. The presence of this self-report historical screen and modules other than cognitive 
evaluation on pre-deployment testing are under review by the Defense Health Board. 
In-Theater Screening 
In-theater screening occurs immediately following an injury event or as soon as operationally feasible, 
using the Military Acute Concussion Evaluation (MACE) developed by DVBIC in 2006 (McCrea, Jaffee, 
Guskiewicz, and Doncevic, 2009). MACE allows medics, corpsmen and frontline providers to assess 
quickly the history of what happened during the event, current symptoms that the SM might experience, a 
focused neurological exam, and measurement of four cognitive domains: orientation, immediate memory, 
concentration, and memory recall. The cognitive exam is the Standardized Assessment of Concussion 
(McCrea, Kelly, and Randolph, 2000), which is commonly used as a sideline assessment of sports-related 
TBI. When combined with other clinical information, this tool helps reveal the presence of any red flags 
that should prompt an immediate referral because of concerns of a more severe brain injury or to further 
evaluation and treatment. The currently deployed MACE has been revised substantially (May 2012) and 
has been validated in combat environments.  
In terms of clinical care, before 2010, screening was customarily self-initiated by SMs with potential 
injury. As a result of an evaluation of in-theater TBI care by both medical and line leadership, concerns 
were addressed regarding whether this process likely under-evaluated many of those at risk. 
Subsequently, policy changes now require that every deployed SM involved in a traumatic event, such as 
motor vehicle collision, and/or within 50 meters of a blast, undergo mandatory medical screening and a 
24-hour period of rest (Department of Defense Instruction 6490.11, 2012). This practice ensures that all 
SMs who are involved in a potentially concussive event are screened in a timely fashion to promote early 
detection of concussion, which will lead to prompt treatment. 
SMs with injuries or medical conditions that require evacuation from theater to Landstuhl Regional 
Medical Center (LRMC) in Germany undergo further evaluation, including screening for concussion or 
mild TBI using MACE. This process also identifies any history of prior combat or non-combat TBI and 
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assesses for the presence of concussion or mild TBI-related signs and symptoms. Patients with ongoing 
symptoms are triaged to a stateside medical facility for further evaluation and, if necessary, treatment. 
Post-Deployment 
Because concussion or mild TBI is not always recognized in theater, screening also occurs through post-
deployment health assessments (PDHA). Four questions, adapted from the Brief TBI Survey (BTBIS) 
(Schwab et al., 2007), currently appear on the PDHA; positive responses to all four questions prompt a 
clinical interview to evaluate fully for mild TBI. Although this criterion is more specific than the DoD 
definition (positive response to questions 1 and 2 only), it allows identification of those with ongoing 
symptoms who are likely in need of medical services. The Institute of Medicine (IOM) recommended 
continued use of MACE and BTBIS for screening of combat-related TBI (Institute of Medicine, 2008). 
Some military treatment facilities perform additional screening. For example, Ft. Carson uses the Warrior 
Administered Retrospective Casualty Assessment Tool (WARCAT) to fully assess possible injuries 
(Terrio et al., 2009). 
VA Clinical Screening and Diagnosis Tools 
Since April 14, 2007, all VA health-care facilities screen all veterans from OEF/OIF for possible TBI 
upon initial contact with the VA health system (England and Mansfield, 2008; U.S. Dept. of Veterans 
Affairs VHA Directive 2007-013). Those who screen positive are referred for follow-up evaluations that 
include a history of the veteran’s injury, a physical examination targeted to the veteran’s symptoms, and 
administration of the 22-item Neurobehavioral Symptom Inventory, an inventory that has been adapted by 
the VA for use in their Comprehensive TBI Evaluation. Veterans Health Administration (VHA) staff 
received training in administering the screening tool and follow-up evaluation, and the computerized 
medical record system was modified to include a TBI screening clinical reminder that 1) identifies who 
needs screening, 2) presents the screening tool to the provider, and 3) enters results into progress notes 
and into the electronic health record. VA policy requires that a veteran who screens positive be offered a 
follow-up evaluation with a specialty provider who can determine whether the patient has a TBI and then 
develop a treatment plan. The evaluation process includes a standardized evaluation template of common 
problems following brain injury, including a complete TBI-specific eye examination (Schwab el al., 
2007). 
 14 
Civilian Clinical Screening and Diagnosis Tools 
The clinical diagnosis of acute TBI in the civilian population is usually based on a history of multiple 
signs and symptoms, including acute alterations in alertness or consciousness or memory problems that 
occur immediately after the event. If the traumatic event is witnessed, confirmation of a change in 
consciousness by an observer (in the context of the mechanical injury) makes the diagnosis. 
Unconsciousness is usually easy to identify, except if brief, whereas alterations in consciousness might 
require confirmation through an interview conducted by a medical expert. Most often the witnesses note 
abnormal behavior, such as disorientation for place or time, poor ability to attend or make new memories, 
or impaired balance and gait. Sports coaches use standardized tests applied shortly after the injury to 
diagnose less marked alteration in consciousness in athletes (Lovell, 2009). 
In moderate and severe TBI, memory impairment during the period of depressed consciousness results in 
retrograde amnesia, lack of memory extending back in time, and impaired memory for details of the 
injury itself and extending for some time after the injury or anterograde amnesia (Sigurdardottir 
Sigurdardottir, Andelic, Roe, and Schanke, 2009). If unwitnessed, the clinical diagnosis of TBI can be 
made in the context of a mechanical event involving the head (scalp wound, hematoma, skull fracture, 
blood behind the tympanic membrane of the ear, or other evidence of a head injury) in someone who has 
amnesia for the time around the event. Persons with isolated head trauma with minimal alteration in 
consciousness might not seek medical attention, making unbiased ascertainment of these cases of mild 
TBI challenging. 
Diagnosis is further complicated by other conditions that might cause alteration or loss in consciousness. 
Alcohol or drug intoxication, hypoglycemia, cardiac arrhythmia, stroke, and seizures can cause rapid 
change in consciousness and might contribute to falls and other mechanisms of injury that can result in 
TBI. Although alcohol can contribute to these injuries, including TBIs, the effect of its role after a TBI 
has occurred is unclear. A study of 38,019 patients with moderate to severe head injuries documented that 
patients who tested positive for alcohol were less likely to die than patients who had no alcohol in their 
bloodstream. These patients had more medical complications during their hospital stay and were younger 
and had less severe injuries (Salim et al., 2009). Additional research indicated that high admission blood- 
alcohol level in patients with isolated moderate to severe TBI was independently associated with 
improved survival (Berry et al. 2010; Berry et al., 2011). These findings suggest that additional research 
is needed to investigate the potential therapeutic use of alcohol in the management of TBI (Salim et al., 
2009; Berry et al. 2010; Berry et al., 2011). 
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The diagnosis of TBI is usually made clinically, and no well-accepted diagnostic tests (e.g., biomarkers or 
imaging) are available for use in standard medical practice to diagnose mild and even some moderate 
TBI. However, neuroimaging is commonly used to detect bleeding inside the skull in persons with TBI 
because posttraumatic bleeding is associated with worse prognosis and can be life threatening. On 
occasion, such evidence of TBI is discovered on neuroimaging in persons in which the clinical suspicion 
of TBI was low. Although not all neuroimaging modalities are able to identify all TBIs, some techniques, 
for example MRI, are better able to identify patients with some potentially critical injuries such as diffuse 
axonal injury (DAI) (Belanger, Vanderploeg, Curtiss, and Warden, 2007; Levine et al., 2006). 
Clinical Presentation/Symptoms 
Diagnosis of acute TBI is based on several criteria, including history of the event, clinical and functional 
assessment, and CT scanning and other neuroimaging. Some of the pathoanatomical features of TBI can 
be diagnosed with neuroimaging. However, standard neuroimaging does not enable comprehensive 
quantitative assessment of the brain injury, so a substantial discrepancy between the degree of clinical 
impairment and the degree of injury is often seen on neuroimaging. This is a major clinical concern, 
especially when trying to understand the neurological mechanisms associated with PCS. Major research 
advances in neurotraumaproteomics (a study of protein complexes that make up the nervous system) have 
identified several candidate markers that are under evaluation as TBI biomarkers. Early research has 
uncovered several candidates that have shown some preclinical potential; these include lactate 
dehydrogenase (LDH), glial fibrillary acid protein (GFAP), neuron specific enolase (NSE), and S-100ß. 
Unfortunately these proteins lack either the necessary sensitivity or brain specificity or both to be used 
effectively alone (Pineda, Wang, and Hayes. 2004; Pelsers, Hermens, and Glatz, 2005; Ingebrigtsen and 
Romner, 2003; Bandyopadhyay, Hennes, Gorelick, Wells, and Walsh-Kelly, 2005; Siman et al., 2004). 
More recently, new candidate biomarkers have been discovered; these include: UCH-L1, MAP-2, and 
TAU proteins (Kobeissy et al., 2006; Zemlan et al., 1999; Folkerts, Berman, Muizelaar, and Rafols, 
1998), and the II-spectrin protein breakdown products (SBDPs) (Pike et al., 2004; Pike et al., 2001; Pike 
et al., 2000; Ringger et al., 2004; Pineda et al., 2007). These findings highlight the need for biomarker 
development and validation. 
Clinical signs and symptoms can occur alone or in combinations and might result in functional 
impairment. These signs and symptoms appear to be independent of pre-existing conditions except in 
cases of exacerbation of pre-existing conditions. They usually can be defined by one or more of the three 
following categories: 
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Physical: headache, nausea, vomiting, dizziness, blurred vision, sleep disturbance, weakness, 
paralysis, sensory loss, spasticity, disorders of speech or language, swallowing disorders, balance 
disorders, disorders of coordination, seizure disorder; 
Cognitive: attention, concentration, memory, speed of processing, new learning, planning, 
reasoning, judgment, executive control, self-awareness, language, abstract thinking; 
Behavioral/emotional: depression, anxiety, agitation, irritability, impulsivity, aggression and 
violence, acting out, noncompliance, social inappropriateness, emotional outbursts, childish 
behavior, impaired self-control, impaired self-awareness, inability to take responsibility or accept 
criticism, or alcohol or drug abuse/addiction. Additional neuropsychiatric problems associated 
with TBI include apathy, paranoia, confusion, frustration, agitation, sleep problems, or mood 
swings (American Psychiatric Association 2000). 
The signs and symptoms listed above are typical of each category but are not an exhaustive list of 
all possible signs and symptoms. 
Severity 
TBI is often characterized by severity that is usually based on various clinical factors, including duration 
or length of LOC, coma scaling, or imaging. Clinicians and investigators have classified TBI as mild, 
moderate, or severe by scores on the Glasgow Coma Scale (GCS), a widely used scoring system to assess 
coma and impaired consciousness (Teasdale and Jennett, 1974; Rimel, Giordani, Barth, Boll, and Jane, 
1981; Rimel, Giordani, Barth, and Jane, 1982). The GCS is an algebraic scale consisting of three 
components: eye opening, verbal response, and motor response (Table 1). Patients with scores of 8 or less 
are classified as “severe”; scores of 9 to 12 are “moderate”; and scores of 13 to 15 are “mild” (National 
Center for Injury Prevention and Control 2003). 
Table 1. Glasgow Coma Scale 
Ability Score 
Eye Opening (E)  
     Spontaneous 4 
     To voice 3 
     To pain 2 
     None 1 
 
Motor Response (M)  
     Normal 6 
     Localized to pain 5 
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     Withdraws to pain 4 
Flexion-abnormal (an abnormal posture that can include rigidity, clenched 
fists, legs held straight out, and arms bent inward toward the body with the 
wrists and fingers bent and held on the chest) 
3 
Extension (an abnormal posture that can include rigidity, arms and legs 




Verbal Response (V)  
Normal conversation 5 
Disoriented conversation 4 
Words, but not coherent 3 
No words, only sounds 2 
None 1 
Score: Eye Score (E) + Motor Score (M) + Verbal Score (V)= 3 to 15 
Teasdale & Jennett, 1974 
 
Although not intended or designed as a severity classification, the LOC duration is often used as an 
approximation of TBI severity by certain users, including CDC. In addition to brief LOC, mild TBI also 
might be characterized by confusion or disorientation or loss of memory for events immediately before or 
after the injury. In contrast, more severe TBI is associated with extended periods of unconsciousness of 
more than 30 minutes, or prolonged post-traumatic amnesia of more than 24 hours. Although the 
distinction between mild TBI and more severe TBI seems straightforward, establishing definitive, 
measurable criteria to identify and quantify the occurrence of mild TBI is challenging because clinicians 
and investigators have been using different diagnostic criteria and methodologies to study this condition 
(Ruff and Jurica, 1999; American Congress of Rehabilitation Medicine, 1993; National Center for Injury 
Prevention and Control, 2003). 
The DoD and VA classify severity for non-penetrating TBI (Table 2) as mild TBI if the length of time of 
LOC was 0 to 30 minutes, provided that the patient does not have a clinical or imaging diagnosis 
indicative of more severe TBI (e.g., a patient with an abnormal imaging who had a LOC of 5 seconds). 
This LOC-related criterion for mild TBI is consistent with the corresponding CDC criterion and ICD-9-
CM classification for concussion (850 series) (National Center for Injury Prevention and Control, 2003). 
DoD and VA also classify TBI as a moderate TBI if the patient has a LOC greater than 30 minutes and 
less than 24 hours; and severe TBI if the patient has a LOC greater than 24 hours. If a patient meets 
criteria in more than one severity category, the higher severity level of severity is assigned. CDC concurs 
with DoD and VA criteria. 
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Current DoD surveillance methods capture penetrating injury as a separate category, regardless of injury 
severity because this injury pattern might have more substantial long-term consequences than non-
penetrating injury. TBI severity for non-penetrating injuries was determined using standard DoD/VA 
severity algorithms. 
If not clinically possible to determine the brain injury level of severity because of medical complications 
(e.g., medically induced coma), other severity markers are required to determine the severity of the brain 
injury. For example, one or more of the following may be useful: imaging studies; monitoring intracranial 
pressure; electroencephalography that may demonstrate absence of electrical brain activity; and, 
transcranial doppler that may detect the absence of blood flow in the brain. 
 
Table 2. DoD/VA Severity Stratification for Non-penetrating TBI 
 Mild Moderate Severe 
Structure Imaging Normal Normal or abnormal Normal or abnormal 
Length of Time of Loss 
of Consciousness 
0-30 mins >30 mins and 
< 24 hours 




A moment up to 24 hrs >24 hrs Severity based on other criteria 
Post-Traumatic 
Amnesia 
0-1 day >1 and <7 days > 7 days 
Glasgow Coma Scale* 13-15 9-12 3-8 
*For purposes of injury stratification, the Glasgow Coma Scale (GCS) is measured at or after 24 hours 
(Malec et al. 2007; Esselman and Uomoto 1995; American Congress of Rehabilitation Medicine, 1993; 
Saatman et al. 2008; Model System). 
Source: Department of Defense and Department of Veterans Affairs. 
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Note: Although the initial severity level might have some prognostic value, it does not necessarily reflect 
the patient's ultimate level of functioning. This requires serial assessments of the patient’s cognitive, 
emotional, behavioral, and social functioning. 
 20 
IV. Treatment 
Various TBI-related activities are being pursued in the areas of medical care, research, and interagency 
collaboration. 
Persons with isolated mild TBI are usually treated and released from emergency departments. These 
patients might receive guidance upon discharge regarding when to seek medical care if symptoms persist 
or worsen and when to return to work, school or sports play (CDC Heads Up to Clinicians available at 
http://www.cdc.gov/concussion/clinician.html). In contrast, TBI survivors with moderate to severe 
injuries are likely to receive treatment in intensive care units and neurosurgical units (U.S. National 
Institutes of Health, February 2002). Treatment depends on the recovery stage of the patient and other 
factors (e.g., concurrent injuries, comorbid conditions). In the acute stage, the primary aim is to stabilize 
the patient and to prevent secondary injuries (U.S. National Institutes of Health February, 2002). 
Rehabilitation is the primary treatment for the sub-acute and chronic stages of recovery (U.S. National 
Institutes of Health, February 2002). 
Acute Care 
TBI care in the Military Health Service (MHS) varies by TBI severity, interval from injury to 
presentation, and physical location where the injury occurs. In 2005, the Brain Trauma Foundation (BTF), 
in collaboration with DVBIC and the Uniformed Services University of the Health Sciences (USUHS), 
published the Guidelines for the Field Management of Combat-related Head Trauma (Knuth et al., 2005). 
These guidelines relied on extrapolated data from civilian trauma settings and recognized that tactical 
operations might alter the care that is provided in the combat setting. A decision-tree included in the 
document gives frontline providers triage decision-making assistance. 
Severe and penetrating TBIs are recognized and triaged at the time of injury. Acute care for conditions 
such as intracranial pressure management, nutrition, and general critical care are consistent with civilian 
best practices (Bullock and Povlishock, 2007). DVBIC, in conjunction with the American Association of 
Neuroscience Nurses, supported recommendations for the Nursing Care of Patients with Severe TBI 
(Mcilvoy and Meyer 2008). Military data suggest that patients with combat-related severe and penetrating 
TBI are at higher risk  than patients with less severe or non-penetrating injuries for the development of 
cerebral vasospasm and vascular injury (Armonda et al., 2006). 
To assist with management of acute injury in theater, civilian and military experts developed clinical 
practice guidelines, Evaluation and Management of Mild TBI/Concussion in the Deployed Setting 
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(Defense and Veterans Brain Injury Center, 2008). These guidelines incorporate consideration of the 
limited resources available in an austere environment, and the co-morbid psychological health (PH) 
conditions that might be present. The Guidelines provide indications for urgent CT scanning, strategies 
for symptom management, and instructions for return to duty evaluations. In most cases, patients with 
mild TBI can be evaluated and treated at the Forward Operating Base for up to 7 days, or up to 30 days at 
more sophisticated recovery centers.   
In late 2009, Concussion Care Centers were established in Afghanistan to provide supervised rest, 
education, treatment, and recovery for SMs with concussion. Using this model of primary care decreases 
the stigma of TBI care, any association with PH, and the development of perceptions of chronic illness. 
For patients not improving in primary care, specialty referrals and management in a dedicated TBI clinic 
are indicated. Neurocognitive testing done in theater can be compared with the patient's baseline, thereby 
better informing return to duty decisions. Since 2010, current DoD guidelines have mandated that 
deployed service members who are in specific, potentially concussive events will undergo standardized 
evaluation with MACE, which avoids reliance on self-reporting and broadens in-theater screening from 
symptom-based to incident-based and includes recommendations for a more detailed evaluation of those 
sustaining recurrent concussions. 
To advance care with best practices, a VA/DoD evidence-based workgroup performed a rigorous 
literature review and developed a Clinical Practice Guideline for the Management of Concussion/Mild 
TBI (Defense and Veterans Brain Injury Center & Defense Centers of Excellence, 2008). These 
guidelines focus on the management of those with sub-acute to chronic injury and include an educational 
component regarding the natural history of concussion and the expectation of recovery. 
Clinical and surgical guidelines have been proposed to guide decisions in TBI treatment, as defined by an 
authoritative examination of current evidence (Maas, Stocchetti, and Bullock, 2008; Brain Trauma 
Foundation, 2011). Surgical interventions, such as those for subdural and epidural hematomas, are 
effective (Bullock et al., 2006). Although some consistency is evident in the clinical management of 
patients with moderate or severe TBI, which is based upon the best available evidence, few of these 
management guidelines are based on large, well-controlled clinical trials (Maas et al., 2012). Difficulty in 
conducting rigorous studies arises because the pathophysiology of TBI is complex and the disruption in 
brain function rarely occurs in isolation. Additionally, heterogeneity in neuropathology occurs from 
person to person (Jennett, Adams, Murray, and Graham, 2001; Adams, Graham, and Jennett, 2001; 
Maxwell et al., 2004). For example, despite success in preclinical or smaller clinical studies, more than 20 
drugs or other therapies for moderate or severe TBI have not demonstrated a positive effect on outcome in 
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large, multi-center phase III clinical trials. Numerous explanations for explaining this discordance exist, 
but the heterogeneity of the patient population is one of the most noteworthy contributing factors 
(Narayan et al., 2002; Saatman et al., 2008). Therefore, nearly all of the treatment guidelines are based 
on smaller studies and case reports, including medical and surgical interventions to attenuate some types 
of acute neurotraumatic injuries. A neurosurgical intervention to reduce intracranial pressure, 
decompressive craniectomy, is one example, although this procedure also remains controversial (Bullock 
et al., 2006). The Brain Trauma Foundation (BTF) has developed guidelines for the management of 
severe TBI based on the best available evidence (Brain Trauma Foundation, 2007); improvements in 
outcomes have been reported in an international study when these guidelines were followed (Arabi et al., 
2010). Similarly, definitive studies to demonstrate the effectiveness of cognitive therapy and other types 
of rehabilitation are lacking, but numerous smaller studies have provided a basis for rehabilitation 
guidelines for TBI (Fadyl and McPherson, 2009; Lane-Brown and Tate, 2009; Cicerone et al., 2008: 
Borg et al., 2004). Large-scale comparative effectiveness research that leverages the variability in practice 
patterns also has been proposed as a means of identifying those treatments associated with better outcome 
(Maas et al., 2011). Despite the lack of class I clinical trials, implementation of guidelines (e.g., the 
BTF’s guidelines) has resulted in improved TBI outcomes (Bulger et al., 2002; Clayton, Nelson, and 
Manara, 2004; Elf, Nilsson, and Enblad, 2002; Fakhry, Trask, Waller, and Watts, 2004; Patel et al., 
2002; Stein Georgoff, Meghan, Mirza, and El Falaky, 2010; Suarez et al., 2004; Varelas et al., 2006). 
Long-Term Care 
Improving continuity of quality care and service delivery along with inter-service, interagency, 
intergovernmental, and public and private collaboration for care are all critical to the success of long-term 
care. In addition, management, transition, and associated training, tracking, and accountability for this 
care are essential for administering such programs. Work in this area includes establishing multiple 
reforms (e.g., implementing uniform training for recovery coordinators and medical and non-medical 
care/case managers, establishing a single tracking system, and providing a comprehensive recovery plan 
for the seriously injured). 
The joint Federal Recovery Coordination Program (FRCP) trains and deploys Federal Recovery 
Coordinators (FRCs) to support medical and non-medical care/case managers in the care, management, 
and transition of seriously wounded and ill SMs, veterans, and their families.  
For veterans and active duty personnel with any loss of vision, blurred vision, or difficulty reading or 
squinting, VA provides comprehensive vision rehabilitation services—often while the injured SM is still 
a patient at a military treatment facility. One hundred and sixty four Visual Impairment Service Team 
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(VIST) Coordinators provide lifetime case management for all legally blind veterans and all OEF/OIF 
patients with visual impairments. Additionally, 75 Blind Rehabilitation Outpatient Specialists (BROS) 
with the VA provide blind rehabilitation training to patients who are unable to travel to a center for the 
blind. These BROS are certified in low-vision rehabilitation and orientation and mobility training and 
work closely with neuro-ophthalmologists and optometrists who specialize in low vision problems. 
VA’s Vet Centers 
VA's Vet Centers, operated by the Readjustment Counseling Service in the VHA, provide community 
outreach and professional readjustment counseling services for war-related psychological readjustment 
problems (England and Mansfield, 2008). Vet Centers treat and address PTSD, family relationship 
problems, lack of adequate employment, lack of educational achievement, social alienation and lack of 
career goals, homelessness and lack of adequate resources, and other psychological problems such as 
depression or substance use disorder. They are community-based facilities, located outside of the larger 
VA medical centers in convenient easy-to-access settings; they embrace a mission that goes beyond 
medical care in providing a holistic mix of services. Vet Centers offer an alternative to traditional mental 
health care that helps many combat veterans overcome the stigma and fear related to accessing 
professional assistance for military-related problems. Eligibility for Vet Center services is based on 
military service in a combat theater and does not require a veteran to complete the enrollment process. 
VA expanded the number of its Vet Centers nationally from 209 in 2007 to 300 facilities and 70 mobile 
units in 2012.  
Since the beginning of OEF/OIF, the focus of the Vet Center program has been on outreach at military 
demobilization, at National Guard and Reserve sites, and at community locations that feature high 
concentrations of veterans and family members. To promote early intervention, the Vet Center program 
hired 100 OEF and OIF veteran returnees to provide outreach services to their fellow combatants. These 
fellow veteran outreach specialists are effective in mitigating veterans' stigma and establishing immediate 
rapport. For example, from early in FY 2003 through the end of FY 2007, Vet Centers have provided 
readjustment services to approximately 268,987 veteran returnees from OEF and OIF. Of this total, more 
than 205,481 veterans were provided outreach services, and 63,506 were provided clinical readjustment 
services by mental health providers in Vet Centers such as individual and group counseling for veterans 
and their families, substance abuse assessment and referral, and screening and referral for medical issues. 
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VA’s Polytrauma System of Care 
In its polytrauma system of care (that is, treatment for multiple complex injuries from the same event—
for example, amputations, burns, hearing loss, and PTSD), the VA offers comprehensive primary and 
specialty health care to veterans and seriously injured active-duty service members and is an 
acknowledged national leader in providing specialty care in the treatment and rehabilitation of TBI and 
polytrauma (Feeley 2007). Since 1992, the VA has maintained four specialized TBI Centers that have 
served as the primary VHA receiving facilities for military treatment facilities seeking specialized care for 
brain injuries and complex polytrauma. In 2005, the VA established its Polytrauma System of Care, 
leveraging and enhancing the existing expertise at these TBI centers to meet the needs of seriously injured 
veterans and active duty service members from operations in Iraq, Afghanistan, and elsewhere. 
The mission of the Polytrauma System of Care is to provide the highest quality of medical, rehabilitation, 
and support services for veterans and active duty service members injured in the service. This integrated 
nationwide system of care has been designed to provide access to life-long rehabilitation care for veterans 
and active duty service members recovering from polytrauma and TBI. The polytrauma system of care is 






Component 1: Regional. The five flagship facilities of the Polytrauma System of Care are Polytrauma/ 
TBI Rehabilitation Centers (PRC) in Minneapolis, MN; Palo Alto, CA; Richmond, VA; Tampa, FL, and 
San Antonio, TX. These centers serve as hubs for acute medical and rehabilitation care, research, and 
education related to polytrauma and TBI. The specialized services provided at each PRC include 
comprehensive acute rehabilitation care for complex and severe polytraumatic injuries, emerging 
consciousness programs, outpatient programs, and residential transitional rehabilitation programs. 
Clinical care specific to TBI is provided by a staff of rehabilitation specialists and medical consultants in 
such fields as physiatry (doctors who specialize in physical medicine and rehabilitation), rehabilitation 
nursing, neuropsychology, psychology, speech-language pathology, occupational therapy, physical 
therapy, social work, therapeutic recreation, prosthetics, and rehabilitation for blind SMs. 
One of the newest programs within the PRCs is the treatment program for patients with severe disorders 
of consciousness. Provision of rehabilitation services for patients who are minimally conscious or 
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minimally responsive is based on expert opinion rather than scientific evidence. Cornerstones of treatment 
for patients with severe disorders of consciousness include aggressive medical care to treat potential 
reversible causes of impaired consciousness (infection, sedation, hormone imbalance); prevention of 
complications (contracture, pressure sores, malnutrition); family support and education. Additional 
interventions often include structured sensory stimulation and trials with medications to increase 
responsiveness. The Disorders of Consciousness Scale is used to monitor response to treatment. 
In 2007, staffing for the PRC teams was increased at each center in response to increased demands of 
patient workload, coordination of care, and support for family caregivers. The PRCs have affiliations and 
collaborative relationships with academic medical centers, enabling a substantial number of PRC’s 
clinical providers to share VA and affiliated positions in training and medical rehabilitation. The inpatient 
rehabilitation programs at the PRCs maintain accreditation by the Commission on Accreditation of 
Rehabilitation Facilities (CARF) for both Traumatic Brain Injury and Comprehensive Rehabilitation. 
Component 2: Network. The Polytrauma/TBI Network Sites (PNS), designated in December 2005, 
represent the second echelon within the Polytrauma System of Care, with one PNS located within each of 
VA's 21 Veterans Integrated Service Networks (VISN). The PNS provides key components of post-acute 
rehabilitation care for persons with polytrauma/TBI, including, but not limited to inpatient and outpatient 
rehabilitation and day treatment programs. The PNS is responsible for coordinating access to VA and 
non-VA services across the VISN to meet the needs of patients recovering from polytrauma and TBI and 
their families. The PNS consults, whenever necessary, with the PRC. 
Components 3 and 4: Facility. In March 2007, the Polytrauma System of Care network was expanded to 
include two new components of care: Polytrauma Support Clinic Teams (PSCT) and Polytrauma Points 
of Contact. With their geographical distribution across the VA, 85 PSCTs facilitate access to specialized 
rehabilitation services for veterans and active duty SMs at locations closer to their home communities. 
These interdisciplinary teams manage the care of patients with stable treatment plans, provide regular 
follow-up visits, respond to new medical and psychosocial problems as they emerge, and consult with 
their affiliated PNS or PRC when more specialized services are required. 
The remaining 40 VA medical centers have an identified Polytrauma Point of Contact who manages 
consultations for patients with polytrauma and TBI and assists with referrals. The Polytrauma Telehealth 
Network links the PRC and PNS through state-of-the-art multipoint videoconferencing capabilities. This 
Network also ensures that polytrauma and TBI expertise are available throughout the system, that care is 
provided at locations and times most accessible to patients, and that clinical activities include remote 
consultations and evaluations of patients and education for providers and families. 
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Another model for using telehealth technology and the sharing of electronic health information along the 
continuum of care is the rural networks of non-VA health facilities currently funded by the Health 
Resources and Services Administration’s (HRSA’s) Rural Veteran’s Health Access Program (RVHAP).  
A key feature of these networks is collaboration between rural healthcare providers and the Department of 
Veteran’s Affairs.  These networks are intended to help eligible entities coordinate innovative approaches, 
collaborative networks, and virtual linkages to increase the delivery of mental health and other healthcare 
services to meet the needs of veterans of Operation Iraqi Freedom and Operation Enduring Freedom that 
reside in remote rural areas. 
Coordination and Transition of Care. Care management across the entire continuum is a critical 
function in the Polytrauma System of Care to ensure lifelong coordination of services for patients 
recovering from polytrauma and TBI. Consistent, comprehensive procedures and processes have been put 
in place to ensure transition of patients from military treatment facilities to VA care at the appropriate 
time, under optimal conditions of safety and convenience for patients and their families. At the direction 
of the VA’s Secretary, 100 Transition Patient Advocates have been recruited nationwide. In addition, the 
VA assigns a care manager to every admitted patient to coordinate services, address emerging medical, 
psychosocial, or rehabilitation needs, and provide patient and family advocacy. 
To facilitate the continuity of medical care, the PRC receives advanced notice of potential admissions, 
initiates a pre-transfer review, and follows the clinical progress until the patient is ready for transfer. In 
addition to record review, clinician-to-clinician communication occurs to allow additional transfer of 
information and resolution of any outstanding questions. 
The DoD and VA also have made substantial progress sharing available electronic health information to 
further coordinate care. DoD is currently transferring DoD medical digital images and electronically 
scanned inpatient health records to the VA polytrauma centers from Walter Reed National Military 
Medical Center, and Brooke Army Medical Center. VA hopes to add the capability to provide this data 
bi-directionally to support any patients returning to DoD for further care. Additionally, VA and DoD are 
supporting the secure direct connection of authorized providers at VA polytrauma centers into the health- 
information systems at Walter Reed National Military Medical Center.  
In addition, the Department of Health and Human Services Office of the National Coordinator and the 
Under Secretary for Health of the Veteran’s Health Administration (VHA) have established a 
Memorandum of Understanding to examine ways to leverage existing resources to develop potential pilot 
sites for Health Information Exchange between rural providers and the VHA.  The VHA Office of Rural 
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Health continues to partner with stakeholders to identify and improve technology adoption in order to 
expand services to the 3.4 million Veterans that live in highly rural areas. 
Psychosocial support for families of injured service members is paramount as decisions are made to 
transition from the acute care setting of a military treatment facility to a rehabilitation setting. This 
encompasses psychological support, education about rehabilitation, the next setting of care, and 
information about benefits and military processes and procedures. VA social worker or nurse liaisons are 
located at 10 military treatment facilities, including Walter Reed National Military Medical Center. In 
addition, a Certified Rehabilitation Registered Nurse is available to provide education to the family on 
TBI, the rehabilitation process, and the PRCs. The Admission Case Manager from the PRC maintains 
personal contact with the family before transfer to provide additional support and further information 
about the expected care plan. VA also has benefit liaisons located at military treatment facilities that refer 
large numbers of patients to the VA to provide an early briefing on the VA services and benefits available 
to patients and families. 
Lastly, the transition from the PRC to the VA Medical Center in or near the home community must 
ensure that the treatment plan is maintained. Records for VA medical care are readily available through 
remote access across the VA system. Follow-up appointments are made before discharge, and the 
transferring practitioners are readily available for personal contact with the receiving provider to ensure 
full communication. Care managers at the PNS and the home VA medical center provide ongoing support 
and problem resolution in the home community, while continually assessing for new and emerging 
concerns. Finally, each PRC team assesses the expected needs at discharge for transportation, equipment, 
home modifications, other such needs, and makes arrangements for assessed needs. 
Recent studies indicate that the number of medical, physical and psychological injuries that are occurring 
as a result of combat injury are resulting in a greater functional burden on SM’s with the need for 
integrated, interdisciplinary care, longer acute and inpatient rehabilitation stays and greater health care 
costs (Sayer et al., 2008; Schneiderman, Braver, and Kang, 2008). One of these studies examined long-
term treatment in four VA acute PRCs for polytrauma and other combat injuries acquired during the first 
4 years of the Global War on Terror (i.e., between October 2001 and January 2006)  (Sayer et al., 2008). 
In this study of 188 persons, 56% had blast-related combat injuries; 53% had closed head injuries and 
44% had penetrating head injuries; and 56% had craniectomy or craniotomy before PRC admission. 
Additionally, those with TBI-related blast injury had a significantly greater number of multiple injuries. 
After rehabilitation, 64% were discharged to home or military bases, 27% to other inpatient service or 
military treatment facilities, 6% to residential day programs, and 3% to nursing homes. The other was a 
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recent cross-sectional study of veterans following deployment to OEF/OIF examined prevalence of mild 
TBI and PTSD. In the population surveyed, approximately 12% of 2,235 respondents reported history 
consistent with mild TBI, and 11% for PTSD (Schneiderman et al., 2008). 
Care in the Civilian Health System 
Transporting severely injured patients directly to the highest level of trauma care (Level I or II trauma 
centers) has been shown to lower mortality (Sampalis et al, 1997; Nirula, Maier, Moore, Sperry, and 
Gentilello, 2010). Trauma centers demonstrate better adherence to the American Association of 
Neurologic Surgeons Guidelines for the Management of Severe Traumatic Brain Injury, including 
immediately available CT scanning, prompt neurosurgical care, and the ability to monitor intracranial 
pressure (ICP), and treatment of intracranial hypertension (Hesdorffer and Ghajar, 2007; Fakhry et al, 
2004).  
CT scanning is used emergently to identify intracranial bleeding, contusion, or consequences of 
penetrating injury. These patients might be unconscious on arrival and require stabilization, mechanical 
ventilation, and intensive care services. In addition, management of co-occuring injuries and meticulous 
medical care is required to prevent deterioration and the many potential complications, such as infections, 
acute respiratory distress syndrome, disseminated intravascular coagulation, brain swelling, and multi-
organ failure. Monitoring of intracranial pressure is common, and algorithms are in use for lowering 
raised intracranial pressure to preserve cerebral blood flow and prevent pressure-related distortion of the 
brain (herniation syndromes). Intracranial bleeding or hematoma might also require neurosurgical 
intervention. 
Guidelines and Best Practices in Civilian Healthcare Systems 
Professional medical societies developed detailed best practice guidelines for the management of severe 
TBI as shown in Table 3.  
Table 3. Guidelines for the Management of TBI 
Guideline Source 
Guidelines for prehospital management of severe TBI second 
edition  
Badjatia et al., 2006 
Guidelines for the management of severe TBI third edition Brain Trauma Foundation., 2007 
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Guidelines for the surgical management of severe TBI Bullock et al., 2006 
Guidelines for the acute medical management of severe TBI in 
infants, children and adolescents second edition 
Kochanek et al., 2012 
Guidelines for field management of combat-related head trauma 
2005 
Knuth et al., 2005 
The Clinical Policy on Neuroimaging and Decision making in Adult 
Mild Traumatic Brain Injury in the Acute Setting 
American College of Emergency Physicians 
and CDC (Jagoda et al., 2008) 
 
Although guidelines for neuroimaging and decision making in adult mild TBI exist (Jagoda et al., 2008), 
there is variability in the use of neuroimaging, decision to admit to hospital or discharge to home, and any 
follow-up planning (Miele and Bailes, 2009; Timmons and Winestone , 2009; Heller and Mass, 2009). 
Focus is usually on identifying those who are at risk for deterioration, usually caused by post-traumatic 
intracranial hemorrhage. Many patients with mild TBI are discharged from emergency departments to 
their home with instructions to return should symptoms worsen. If all goes well, follow-up is usually first 
suggested with the patient’s primary physician but often this follow-up does not occur (Sosin et al., 1996). 
U.S federal agencies, international agencies, and professional organizations have developed best practice 
guidelines for the management of TBI. For example, the VA and DoD have developed joint clinical 
practice guidelines for the management of concussion/mild TBI (U.S. Dept. of Veterans Affairs & U.S. 
Dept. of Defense, 2009); the American Academy of Neurology has developed guidelines for neurologists 
regarding the management of concussion in sports (American Academy of Neurology, 1997); the CDC, 
convening an expert panel, developed guidelines for coaches on how reduce the numbers of mild TBI and 
how to recognize cases of mild TBI (http://www.cdc.gov/concussion/HeadsUp/online_training.htm); and 
an expert consensus group from Canada has developed clinical guidelines for mild TBI and persistent 
symptoms (Marshall, Bayley, McCullagh, Velikonja, and Berrigan, 2012). Certain states also have 
enacted legislation requiring student athletes who sustain a concussion to be seen by a medical expert 
before they can return to play (National Conference of State Legislatures, 2013). 
Rehabilitation 
A 1998 NIH Consensus Conference on TBI concluded that some evidence supported the use of 
rehabilitation strategies for TBI, but definitive evidence from large well-controlled clinical trials was 
lacking. Despite more than 10 years of effort, clinical practice for the rehabilitation of patients with TBI 
has not advanced substantially. Only limited interventions have demonstrated effectiveness in improving 
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outcomes for patients in rigorous controlled studies (Vanderploeg et al., 2008; Cicerone et al., 2005; 
Levine et al., 2000). One study actually reported that the overall benefit of inpatient cognitive 
rehabilitation for patients with moderate to severe TBI was similar to that of in-home rehabilitation 
(Salazar et al., 2000). Thus, the translation to wide-scale clinical adoption is still premature. In the 
absence of strong evidence, and faced with pressing clinical needs, providers have adopted practices 
based upon consensus and clinical experience (Fadyl and McPherson,  2009; Lane-Brown and Tate, 
2009; Cicerone et al., 2008). The challenge to develop effective rehabilitation strategies for TBI patients 
overlaps with those described earlier in this report regarding acute treatment. At the same time, the 
progress in contemporary neuroscience, imaging, and cell biology is noteworthy—it will ultimately 
provide the foundation for effective remediation of TBI. 
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V. Prognosis and Recovery 
Proper identification of the long-term and lifelong medical signs and symptoms of TBI are critical to the 
study of the epidemiology of TBI-related disability, including the identification of cases of TBI; this 
however, poses some challenges. Recovery after severe TBI can be protracted. Patients might partially or 
completely improve after spending weeks, months, or years in states devoid of purposeful behavior; 
patients might recover their ability to speak, walk, and make new memories. The ability to predict which 
TBI survivors will recover functional independence in society is poor (Mushkudiani et al., 2007). 
Moreover, what prompts recovery and the speed, duration, and extent of recovery is not well understood. 
Predicting the future ability of the severe TBI survivor to return to the workforce is even more difficult. 
Meticulous medical care in the rehabilitation setting enables recovery, but the role of specific 
rehabilitation strategies in accelerating recovery after the various forms of TBI is unknown. The majority 
of scientific investigations of recovery after brain injury focus on focal brain injury, especially stroke. 
Whether or not the lessons learned from these studies can be extrapolated to TBI is not clear. Intense 
study of the biology that underlies the recovery processes associated with functional recovery after TBI is 
warranted.  
Gaps in knowledge severely complicate surveillance methodologies and processes to define the burden of 
illness related to previous TBI. Most difficult is identifying those persons who develop a post-concussive 
syndrome after a mild TBI. This is further complicated in persons with comorbidities, such as depression, 
personality disorder, or substance abuse, which can cause some of the symptoms seen in post-concussive 
syndrome. Another challenge for surveillance of TBI is a the lack of a working definition of “full 
recovery” vs. “persistent disability,” which can occur in persons following TBI. 
Recovery from TBI 
Recovery after TBI is highly variable (Moppett, 2007) and depends on many factors. Outcomes and 
recovery can be measured in several forms and aspects. The 25 most common measures used in the field 
of brain-injury rehabilitation and assessment have been compiled by the Center for Outcome 
Measurement in Brain Injury (COMBI). COMBI is a collaborative project of 16 brain-injury facilities or 
centers, most of them Traumatic Brain Injury Model Systems (TBIMS) through grants funded by the 
Department of Education’s National Institute on Disability and Rehabilitation Research (U.S. Dept. of 
Education, 2012). The most important factor appears to be the severity of the injury (Schretlen and 
Shapiro, 2003). Milder injuries, which are present in 80% – 90% of TBI survivors, are associated with 
better outcomes than those with more severe injuries. Many people classified as having a mild TBI might 
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experience complete resolution of symptoms and return to work and other pre-injury activities. Return to 
work is considered an important metric of recovery, although it is inadequate for children and retired 
adults and it is important to recognize that many adults with disabilities successfully participate in the 
workplace.  Estimates indicate that 10% –50% of persons with a mild TBI experience long-term health 
issues such as persistent headache, difficulty with memory or concentration, or mood changes (Moppett, 
2007; Thornhill et al., 2000). Persons who sustain more severe injuries have worse outcomes, with only 
20% making a good recovery, as assessed by the Glasgow Outcome Scale (Thornhill et al., 2000). The 
course of recovery is also faster following mild TBI, occurring largely within 1 – 3 months, compared 
with 2 or more years in more severely injured groups. In rare cases, and for unknown physiological 
reasons, recovery from a persistent vegetative state or minimally conscious state can occur years after the 
TBI (Schiff et al.,2007; Berube et al., 2006). The ability to predict which severe TBI survivors will 
recover functional independence is poor (Mushkidiani et al., 2007). 
A retrospective analysis of data from clinical trials that tested treatments in adults with severe TBI 
revealed that increasing age was strongly predictive of worse outcomes (Mushkudiani et al., 2007). Race 
and education also might affect outcomes. Studies have determined that African Americans and Asians 
with a history of TBI have lower odds of being employed up to 5 years post injury compared with whites 
who have a history of TBI. (Gary et al.,2009; Berry, Ley, Mirocha, and Salim, 2010). In 1998, another 
report indicated that persons who were employed at the time of injury, had higher educational levels, and 
less disability from their injuries were most likely to be employed at 1–3 years after their injury (Gollaher 
1998). The reasons for these findings need to be explored further. Some studies suggest that women have 
worse outcomes following TBI (Slewa-Younan van den Berg, Baguley, Nott, and Cameron, 2009), 
whereas others report no gender difference (Mushkudiani et al., 2007). Further complicating this picture 
are animal studies that have demonstrated better recovery in females (Stein, 2004). 
Research has demonstrated that the type of injury and certain complications might influence the acute and 
long-term consequences of TBI. Penetrating injuries have worse outcomes than closed injuries 
(Wertheimer, Hanks, and Hasenau, 2008). Comorbidities and secondary injuries, such as low blood 
pressure that might result from severe blood and fluid loss from other injuries, negatively affect outcomes 
after TBI (Butcher et al., 2007). Genetic factors also might play a role. Certain reports indicate that those 
persons who have a gene variant associated with Alzheimer’s disease, apolipoprotein E4, also are more 
likely to have poorer outcomes following TBI (Nathoo Chetty, van Dellen, and Barnett, 2003; Wilson and 
Montgomery, 2007). The majority of experimental preclinical investigations of recovery after brain injury 
use models of focal brain injury. Clarifying whether this information can be extrapolated to diffuse forms 
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of TBI such as diffuse axonal injury and edema is critical. Intense study of the biology that underlies the 
recovery processes associated with functional recovery after TBI is warranted. 
Post-Concussive syndrome (PCS) 
PCS is a term used to describe disabling symptoms following a neurotraumatic event even when no 
intracranial pathology is detected with imaging (Bigler, 2008). At least two major hypotheses exist 
regarding the neural substrate for PCS. One is that PCS is caused by diffuse axonal injury, which results 
in a loss of connectivity between regions of the brain and subsequent behavioral alterations (Smith, 
Meaney, and Shull, 2003; Bazarian et al., 2007; Gold and Lipton, 2008). Diffuse axonal injury is not yet 
reliably detected with CT scans or other neuroimaging tools, but rapid progress is being made in this area. 
DTI appears to be a promising diagnostic tool for diffuse axonal injury (Inglese et al., 2005; Sharp and 
Ham, 2011). 
A second hypothesis is that persistent metabolic alterations in injured, but not lethally injured, brain cells 
result in neuronal dysfunction and subsequent behavioral impairments (Marcoux et al., 2008). Metabolic 
alterations following TBI have been reported using sophisticated imaging tools, such as SPECT, PET, and 
functional MRI, but these methods lack accepted validation for routine clinical use. These hypotheses 
might both be correct, occurring in separate subsets of persons with TBI. These processes also might both 
be linked to one underlying mechanism of injury. For example, that metabolic alterations in grey matter 
are caused by reduced neuronal activity secondary to a loss of connectivity from diffuse axonal injury 
might be possible. 
A better understanding of the pathophysiology of PCS and mild TBI and the development and validation 
of more sensitive imaging tools is a priority for TBI research. Although many persons seek medical 
attention immediately or shortly after a TBI, diagnosis can occur at later points in time. Other potential 
(not yet validated) diagnostic tools for TBI include electroencephalography (EEG); near infrared 
spectroscopy (NIRS); sensory tests for vision, hearing, and balance, and cognitive and motor assessments 
(Suchoff et al., 2008; Arenth, Ricker, and Schultheis, 2007; Pickett, Radfar-Baublitz, McDonald, Walker, 
and Cifu, 2007). 
Posttraumatic Stress Disorder (PTSD) 
PTSD is defined by the DSM-IV criteria as a syndrome occurring in response to a stressor that was a 
serious threat and the person’s response to that threat includes intense fear, helplessness, or horror 
(American Psychiatric Association, 2000). Although PTSD symptoms have been reported in patients with 
moderate and severe TBI, preliminary data from DoD suggests that TBI patients who have lost 
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consciousness tend not to acquire this condition. Persons with LOC resulting from TBI and no memory 
for the traumatic event might not experience the PTSD-like response to the trauma. Similarly, persons 
with PCS infrequently recall the event or have persistent avoidance of stimuli associated with the trauma. 
The symptoms of PCS and the PTSD symptom cluster, called hyper-arousal symptoms, tend to overlap. 
Symptoms such as irritability or outbursts of anger, concentration difficulties, and sleep disturbances 
occur in both PCS and PTSD and are included in the DSM-IV criteria for PTSD (American Psychiatric 
Association, 2000). They also occur in various physical and psychological disorders. Hypervigilance and 
excessive startle response are included in the hyper-arousal symptom cluster for PTSD but are not 
common in PCS. Symptoms common to PTSD appear to occur in greater proportions in those with mild 
TBI compared with other injuries (Hoge et al., 2008). In a study of 2,525 soldiers returning from 
OEF/OIF, headache was found to be the only symptom with strong association to mild TBI alone (Hoge 
et al., 2008). The approximately one-third of SMs with mild TBI who are also diagnosed with PTSD fare 
worse on neurocognitive tests of executive functioning and processing speeds than those diagnosed only 
with mild TBI (Nelson, Yoash-Gantz, Pickett, and Campbell, 2009; Hoge et al., 2008; Brenner et al, 
2009). 
Long-term Health Outcomes or Disability 
The list of neurologic and other problems associated with TBI is long. Cognitive deficits, such as memory 
impairments, are hallmarks of TBI. Tasks involving complex cognition, including executive function 
requiring attention, judgment and insight, are particularly problematic for people with TBI, whereas 
simpler cognitive tasks such as keeping track of daily responsibilities or appointments might not reveal 
deficits (Silver, McAllister, and Arciniegas, 2009).  
Neuropsychiatric disorders, including depression, anxiety, PTSD, suicidal tendencies, disinhibition, and 
substance abuse, have been reported following TBI (Silver et al., 2009; Belanger et al., 2011). These 
neuropsychiatric and emotional disorders might create the most serious challenges to returning to work or 
other pre-injury activities and to community reintegration. Posttraumatic seizures are common after 
penetrating head injury or traumatic intracranial hemorrhage; TBI is the largest known risk factor for 
epilepsy (Temkin, 2009).  
TBI also can produce movement and sensory disorders that disturb balance, vision, perception, and 
hearing (Katz, Zasler, and Zafonte, 2007). Headaches, pain, sleep disturbances, and fatigue are other 
frequent symptoms following TBI (Formisano, Bivona, Catani, D’Ippolito, and Buzzi, 2009; 
Nampiaparampil, 2008; Rao et al., 2008). The association of TBI with later development of Alzheimer’s 
disease or chronic traumatic encephalopathy is the subject of continued study. 
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On December 10, 2012, VA published a proposed rule to amend its adjudication regulations concerning 
service connection for secondary illnesses associated with TBI.  The proposed amendment is in response 
to a report of the National Academy of Sciences, Institute of Medicine (IOM), Gulf War and Health, 
Volume 7:  Long-Term Consequences of Traumatic Brain Injury.  The effect of this proposal would be to 
establish that if a veteran who has a service-connected TBI also has one of five diagnosable illnesses, then 
that illness will be considered service connected as secondary to the TBI, which may provide additional 
benefits to the veteran.   
Specifically, VA’s proposed regulation states: 
(d) Traumatic brain injury.  (1) In a veteran who has a service-connected traumatic brain injury, the 
following shall be held to be the proximate result of the service-connected traumatic brain injury (TBI), in 
the absence of clear evidence to the contrary: 
(i) Parkinsonism following moderate or severe TBI; 
(ii) Unprovoked seizures following moderate or severe TBI;  
(iii) Dementias (presenile dementia of the Alzheimer type and post-traumatic dementia) if 
manifest within 15 years following moderate or severe TBI; 
(iv) Depression, if manifest within 3 years of moderate or severe TBI, or within 12 months of 
mild TBI; or 
(v) Diseases of hormone deficiency that result from hypothalamo-pituitary changes if manifest 
within 12 months of moderate or severe TBI. 
VA received over 200 public comments on the proposed rule and is now preparing the final rule for 
publication. 
Risk of Neurodegenerative Disease Following TBI 
Epidemiologic evidence indicates that synergy exists between TBI and permanent neurodegeneration. 
Longitudinal MRI-based studies have demonstrated brain atrophy occurring in the months to years after 
TBI (Ross,  2011). Contradictory findings regarding the relationship between TBI and Alzheimer’s 
disease exist (Van Den Heuvel et al. 2007). Evidence suggests that risk for dementia is increased two to 
four fold after moderate or severe TBI, but risk following mild TBI is unclear (Shively, Scher, Perl, and 
Diaz-Arrastia, 2012).  
Additionally, evidence indicates that repetitive TBI can cause a unique neurodegenerative disorder first 
reported in boxers and called dementia pugilistica (Martland, 1928). Now termed chronic traumatic 
encephalopathy (CTE), this disorder is characterized by the aggregation of the microtubule-associated 
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protein called tau in nerve cells. This is the same protein that aggregates inside dying neurons in 
Alzheimer’s disease and in the brains of persons with a tau gene variant that causes fronto-temporal 
dementia. Some studies demonstrate that tau aggregation, once started, has the ability to spread from one 
nerve cell to another; this could explain how an initial focal injury could lead to widespread damage over 
time (de Calignon et al. 2012). The genetic variant apolipoprotein E4, a known risk factor for 
Alzheimer’s disease, has been associated with poorer outcomes after head injury (Nathoo et al., 2003) and 
in some studies with increased risk for the later development of Alzheimer’s disease (Graham et al., 
2002; Luukinen et al., 2005; Rabadi and Jordan, 2001; Jordan et al., 1997). However, this association 
has not been found in all studies (Jellinger, 2004). More recently, CTE has been described in athletes who 
participated in contact sports and in 21 veterans (86% of whom were also athletes) (Goldstein et al.2012; 
McKee et al., 2009). Sharing symptoms with PTSD, patients who died with CTE have been described to 
present with poor concentration and memory, irritability, depression, and suicidality. The extent of the 
burden of CTE in service members exposed to TBI is unknown. 
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VI. Surveillance 
Case Definition Background 
Public health surveillance is the ongoing, systematic collection, analysis, interpretation, and dissemination 
of data on a health-related event, such as TBI, for use in reducing morbidity and mortality and to improve 
health (CDC, 2001). Surveillance is a labor-intensive process and requires adequate funding, manpower, 
and, very frequently, a solid public health infrastructure to be successful and sustainable (CDC, 2001). 
For the purposes of this report and based on accepted requirements for identifying cases for surveillance 
purposes, CDC and NIH, in consultation with the Secretary of Defense and the Secretary of Veterans 
Affairs, have defined a case of “traumatic brain injury (TBI) in people formerly in the military” as any 
combat or non-combat TBI that occurred in a person while serving in the U.S. military (from now on 
termed military service-related TBI) since the beginning of military operations in the first Gulf war on 
January 17, 1990 (Atkinson, 1993). This time-linked case inclusion criterion can be modified if additional 
resources become available (i.e., supplementing or changing existing systems). 
Surveillance data can be used to estimate the magnitude of a public health problem, understand the 
natural history of a condition, detect epidemics, document the distribution and spread of a health event, 
test hypotheses about etiologies, evaluate control measures and develop and implement prevention 
interventions (Teutsch, 2000). 
Standard clinical and surveillance case definitions assist in identifying new cases of TBI and cases with 
persistent symptoms, impairments, functional limitations, or disabilities resulting from this condition. 
Historically, each of the departments and agencies involved in this report has used agency/department-
specific standard TBI definitions to meet their mandates and needs, but for public health surveillance, the 
definition described above is used. TBI definitions used by clinicians and investigators may vary, 
especially for cases of mild TBI (National Center for Injury Prevention and Control, 2003; Culotta, 
Sementilli, Gerold, and Watts,1996). The WHO Collaborative Center Task Force on mild TBI published a 
comprehensive review of definitions. They found that 62% of the definitions reviewed incorporated GCS 
scores, but differing ranges of scores (13–15, 14–15, or only 15) was evident. LOC or amnesia was 
required in some definitions, but the duration of LOC varied. The WHO task force concluded that 
surveillance would benefit from a common definition and collaborated with CDC and other agencies and 
groups to develop one (Carroll, Cassidy, Holm, Kraus, and Coronado, 2004). 
In 2009, TBI researchers from CDC/NCIPC, NIH, DoD, VA, and other federal and nonfederal partners 
recommended standardized clinical and surveillance case definitions and data elements for TBI research 
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(National Institute for Neurological Disorders and Stroke, 2013). Although certain evidence-based 
definitions are still under revision due to the paucity of research, their use by all federal agencies and 
partners might allow better TBI-related research and comparability of data collected in the United States. 
Although CDC, NIH, DoD, and VA agree on a common clinical definition for TBI, different perspectives 
are evident among CDC, Centers for Medicare and Medicaid Services (CMS), NIH, VA, and DoD, and 
other stakeholder groups, on how to code multiple clinical manifestations of this condition with codes of 
the International Classification of Diseases (ICD). CDC, NIH, DoD, and VA believe that ongoing 
interaction and discussion is foundational to advancing TBI-related epidemiologic and clinical research. 
As more is learned about the natural course of TBI, CDC, NIH, DoD, and VA have committed to 
continue their collaborations and to extend that to other public and private sector stakeholders and 
partners to improve and standardize TBI-related definitions (for clinical and epidemiologic purposes), 
which will be used in all federally funded TBI research. As such, codes of the ICD-9-CM (to identify TBI 
survivors), ICD-10 (to identify TBI deaths) and the future ICD-10-CM (to identify TBI survivors) 
classifications will be evaluated continuously. This evaluation process will improve identification of cases 
of TBI when analyzing ICD-coded administrative or vital statistics databases in the United States. The 
agencies and partners are committed to this collaborative work that will improve TBI coding and 
classification, while adhering to structure and conventions of the ICD. 
Conceptual and Operational Definitions 
To properly and accurately identify patients with TBI, clinicians, researchers, and investigators use 
conceptual and operational definitions. 
A conceptual case definition provides criteria to identify a case of TBI for surveillance purposes based 
on selected clinical signs, symptoms, and neuroimaging. This definition is necessary as a reference 
standard for the evaluation of operational or working definitions of mild TBI used by surveillance 
systems. 
An operational case definition provides quantifiable criteria to consistently identify cases of TBI for 
surveillance purposes when reviewing ICD-coded health-care administrative or vital statistics databases, 
when abstracting information from medical records, or when analyzing data from surveys and personal 
interviews. Operational definitions should be designed to approximate the conceptual definition as closely 
as possible. Operational definitions might be based on clinical symptoms, clinical records (clinical 
definition) or based on existing diagnostic coding (e.g., those found in death certificates or administrative 
hospital data bases). 
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Clinical Case Definition 
CDC issued the following clinical case definition for TBI regardless of injury severity in its 1995 
publication, Guidelines for Surveillance of Central Nervous System Injury (Thurman et al., 1995). 
Clinical Case Definition 
For surveillance systems using data from clinical records, a case of TBI (craniocerebral trauma) is defined 
as an occurrence of injury to the head that is documented in a medical record, with one or more of the 
following conditions attributed to head injury:* 
 observed or self-reported decreased level of consciousness,† 
 amnesia,‡ 
 skull fracture, 
 objective neurological or neuropsychological abnormality,§ or 
 diagnosed intracranial lesion** 
* Injuries to the head might arise from blunt or penetrating trauma or from acceleration-deceleration 
forces. 
† Decreased level of consciousness refers to partial or complete loss of consciousness. This includes 
states described as less than full mental capacity, stupor, or coma. 
‡ Amnesia might include loss of memory for events immediately preceding the injury (retrograde 
amnesia), for the injury event itself, and for events subsequent to the injury (posttraumatic amnesia). 
§ Neurological abnormalities are determined from neurological examination. Examples include 
abnormalities of motor function, sensory function, or reflexes; abnormalities of speech (aphasia or 
dysphasia); or seizures acutely following head trauma. Neuropsychological abnormalities are 
determined from mental status and neuropsychological examinations. Examples include disorders of 
mental status (such as disorientation, agitation, or confusion) and other changes in cognition, behavior, 
or personality. 
**Examples of diagnosed intracranial lesions include traumatic intracranial hematomas or hemorrhage 
(epidural, subdural, subarachnoid, or intracerebral), cerebral contusions or lacerations, or penetrating 
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cerebral injuries (e.g., gunshot wounds). The diagnosis of such intracranial lesions is usually confirmed 
with a CT or MRI brain scan or by other neurodiagnostic procedures. 
The clinical definition of TBI excludes the following: 
 lacerations or contusions of the face, eye, ear, or scalp, without other criteria listed above 
 fractures of facial bones, without other criteria listed above 
 birth trauma 
 primary anoxic, inflammatory, infectious, toxic, or metabolic encephalopathies that are not 
complications of head trauma 
 neoplasms 
 brain infarction (ischemic stroke) and intracranial hemorrhage (hemorrhagic stroke) without 
associated trauma 
Definition of TBI based on ICD Diagnostic Coding 
The ICD has been used worldwide to code and classify morbidity and mortality data enabling health-care 
providers to code specific diagnoses. In the United States, some versions of the ICD are used to code and 
classify mortality data only; since 1999, the tenth version of WHO’s ICD-10 (World Health Organization 
1992) is used to code and classify such data from death certificates. 
Clinical modifications (CM) of the ICD have been produced with authorization from WHO to classify 
morbidity (as opposed to classify mortality). A clinical modification of the WHO ninth revision of ICD 
(ICD-9-CM; Centers for Disease Control and Prevention, 2009) is being used in the United States to 
code diagnoses, including those of TBI. To replace ICD-9-CM, a clinical modification of the ICD-10, 
known as ICD-10-CM, has been developed by CDC/National Center for Health Statistics (NCHS) with 
input from health-care industry stakeholders; this version will be implemented on October 1, 2014. 
TBI Morbidity 
Morbidity codes currently in use were last updated in 2001. The ICD-9-CM codes recommended for 
inclusion in the definition of TBI at this time include the following: 
800.0 – 801.9  Fracture of the vault or base of the skull 
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803.0 – 804.9  Other and unqualified and multiple fractures of the skull 
850.0 – 854.1  Intracranial injury, including concussion, contusion, laceration, and hemorrhage 
950.1 – 950.3  Injury to the optic chiasm, optic pathways; and visual cortex 
959.01  Head injury, unspecified (beginning 10/1/97) 
995.55  Shaken Infant Syndrome 
Since 2001, additions have been made to ICD-9-CM codes to address emotional and behavioral 
symptoms of TBI. VA and DoD proposed these additions in response to a request from Congress to 
address concerns by SMs and veterans who are receiving mental health diagnoses for symptoms of TBI. 
This is particularly important due to the stigma related to mental health issues as compared to physical 
injuries.  Some of these changes were consistent with ICD and accepted by NCHS. These changes 
resulted in the inclusion of TBI as a clinical term in ICD-9-CM. VA and DoD also proposed a new code 
for history of traumatic brain injury (V15.52) and a new code section for signs and symptoms involving 
emotional state. These new codes allow emotional and behavioral symptoms of TBI and other conditions 
to be coded without assigning a mental health diagnosis. In addition, VA and DoD have proposed 
including these codes for several TBI-associated cognitive symptoms. 
As the United States starts to replace the current ICD-9-CM coding system with ICD-10-CM, an 
opportunity exists to improve TBI classification. Federal stakeholders have been concerned regarding the 
need for a better classification for TBI symptoms using ICD codes as acute or persistent (or chronic) for 
both epidemiologic and clinical uses. CDC, NIH, DoD, VA, and other federal agencies are reviewing 
proposed codes of ICD-10-CM classification and making suggestions for changes that would improve 
TBI reporting in the United States. 
Although different perspectives exist among CDC, NIH, DoD, VA and other stakeholders, and because 
knowledge gaps are apparent regarding the natural course of TBI, these agencies support ongoing 
interaction and discussion, which is foundational to advancing TBI-related epidemiologic and clinical 
research. For example, little is known about the pathophysiology and the long-term effects of blast-related 
TBI. CDC, NIH, DoD, and VA will continue to work together and with other public and private sector 
stakeholders to 1) standardize all TBI-related definitions to be used in all federally funded TBI research in 
the United States (Thurmond et al., 2010; National Institute for Neurological Disorders and Stroke, 2013) 
and 2) propose modifications to the ICD-CM that are consistent with the structure and conventions of the 
classification that will improve identification of cases of TBI in the United States. 
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TBI Mortality 
For TBI Mortality (based on ICD-10 codes). The ICD-10 codes recommended for inclusion in the 
definition of TBI at this time include the following: 
S01.0 – S01.9  Open wound of the head 
S02.0, S02.1, S02.3, S02.7 – S02.9  Fracture of skull and facial bones 
S04.0  Injury to optic nerve and pathways 
S06.0 – S06.9  Intracranial injury 
S07.0, S07.1, S07.8, S07.9  Crushing injury of head 
S09.7 – S09.9  Other and unspecified injuries of head 
T01.0  Open wounds involving head with neck 
T02.0  Fractures involving head with neck 
T04.0  Crushing injuries involving head with neck 
T06.0 Injuries of brain and cranial nerve with injuries of 
nerves and spinal cord at neck level 
T90.1, T90.2, T90.4, T90.5, T90.8, T90.9 Sequelae of injuries of head. 
 
Case Ascertainment by Severity 
The use of ICD-9-CM to classify TBI severity is problematic since coding is not consistent with 
conceptual and clinical definitions for mild, moderate, and severe TBI. This is especially problematic for 
differentiating mild from moderate TBI. As illustrated by Table 4, persons with LOC 30 minutes to 1 
hour would be categorized as mild, rather than moderate since ICD 9-CM, does not differentiate persons 
with LOC of less than 30 minutes from those with LOC of 30 minutes to 1 hour. Injuries that include 
brain contusion, hemorrhage, or laceration will be categorized as moderate or severe, depending on LOC 
and the severity of the focal injury. However, it may not always be possible from ICD-9-CM codes to 
distinguish between moderate and severe TBI, especially if LOC is not stated. For persons with more than 
one TBI diagnosis, severity should be consistent with the most severe diagnosis. 
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Table 4. Stratification of Severity by Length of time of Loss of Consciousness 
Classification Mild Moderate Severe 
DoD/VA Common 
Definition  
0-30 mins >30 mins and < 24 hrs >24 hrs 
Classification Brief LOC Moderate LOC Prolonged LOC 
ICD-9-CM No LOC; brief <1 hr (30 
mins or less, 31 mins to 
59 mins) 
1 to 24 hrs >24 hrs 
V15.5 DoD/VA 
Extenders 
< 1 hr 1 to 24 hrs >24 hrs 
Source: Department of Veterans Affairs (VA) and Department of Defense (DoD). 
Because of these inconsistencies, VA and DoD previously proposed adding synonyms in ICD-9-CM as 
follows: “mild TBI” for LOC <30 minutes, “moderate TBI” for LOC >30 minutes to <24 hours, and 
“severe TBI” for LOC > 24 hours. This proposal was intended to aid clinicians and coders in selecting the 
correct acute injury code. In the ICD-9-CM review process, the proposals, however, were not supported 
by stakeholders. VA continues to advocate for a simple revision to ICD-10-CM before the activation in 
2014. This revision would eliminate possible coding errors with “concussion” by limiting that section to 
true concussion (mild TBI, LOC < 30 minutes), and move the remainder of codes in that section to "other 
intracranial injuries" (S06.89).  
DoD V15.5 code-related extenders to stratify TBI severity. DoD uses an additional set of internal 
codes to stratify injury. A series of extenders appended to ICD-9-CM code V15.5 (i.e., personal history of 
injury) indicate severity based on LOC and to indicate SM's deployment. These extenders are not valid 
ICD-9-CM codes and are not recognized by other users of the ICD-9-CM classification in the United 
States. Therefore, any data collected using these codes will be applicable to military settings only. In 
addition, new V15.5 codes were proposed and implemented (e.g., code V15.52 - History of TBI, was 
implemented on October 1, 2009). 
Mild TBI 
In 2003, a CDC Definitions Subgroup of the CDC Workgroup on mild TBI produced and recommended a 
definition for mild TBI (CDC, 2003). This definition for mild TBI, however, does not categorize other 
levels of TBI severity (i.e., moderate or severe) and might not be well suited for surveillance of mild TBI 
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not treated in hospital or Emergency Department (ED) settings. Based on this definition (CDC, 2003), the 
CDC mild TBI Working Group recommended the following three operational or working definitions for 
case ascertainment based on 1) interviews and surveys; 2) health-care administrative data sets; and 3) 
clinical records. 
Interview/Survey. Mild TBI is recognized when a person or proxy surveyed or interviewed affirms the 
occurrence, in the period under surveillance, of a nonfatal injury to the head that is accompanied by the 
following conditions: 
 Criteria consistent with the recommended conceptual case definition (occurrence of injury to the 
head resulting from blunt trauma or acceleration or deceleration forces that result in any period of 
observed or self-reported transient confusion, disorientation, impaired consciousness, and 
amnesia around time of injury; or observed signs of other neurological or neuropsychological 
dysfunction, such as seizures, headache, irritability, fatigue and poor concentration); 
 Loss of consciousness or altered consciousness; 
 Loss of memory for events immediately before, during, or after the injury. 
Surveys and interviews should ask whether health-care professionals evaluated such injuries and, if so, 
what level of care was provided. Where possible, analyses of data should distinguish among persons who 
received no medical care, non-hospital-based care which includes physician office visits, hospital 
emergency department care, inpatient hospital care up to 24 hours, and inpatient hospital care of greater 
than 24 hours. Unfortunately, these data have not typically specified whether the TBI or some other injury 
was the reason for the length of stay, but occurrences of brain injury with inpatient hospital care of greater 
than 24 hours may be classified as more severe because they do not meet the criteria for mild TBI. 
ICD-9-CM based Definition. Mild TBI is recognized among persons treated in health-care facilities and 
who are assigned the following ICD-9-CM (International Classification of Diseases, Ninth Revision, 
Clinical Modification) diagnostic codes: 
ICD-9-CM First Four Digits = 800.0, 800.5, 801.0, 801.5, 803.0, 803.5, 804.0, 804.5, 850.0, 
850.1, 850.5 or 850.9: 800-804- Skull Fracture; 850-854 Intracranial Injury, excluding those with 
skull fracture 
ICD-9-CM Fifth Digit subclassification is required for categories 851 to 854 to identify 
loss of consciousness, if any, and the length of time as follows: 
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• 0, unspecified state of consciousness; 
• 1, with no loss of consciousness; 
• 2, with brief (less than one hour) loss of consciousness; 
• 6, with loss of consciousness of unspecified duration; and 
• 9, with concussion, unspecified. 
 
ICD-9-CM First Four Digits = 959.0: Injury, Other and Unspecified 
ICD-9-CM Fifth Digit = 1, with no loss of consciousness. 
These codes indicate either skull fracture or concussion without evidence of underlying brain hemorrhage 
or contusion, and no more than brief LOC. It is important to note that although the fifth digit 2 is being 
used to indicate mild TBI, this ICD-9-CM code is problematic for indicating severity. A fifth digit of 2 
indicates loss of consciousness less than1 hour. As mentioned above (Table 4), the clinical definition used 
by DoD/VA of mild TBI includes only those patients with loss of consciousness of less than 30 minutes. 
However, the ICD-9-CM does not differentiate between LOC of less than 30 minutes and 30 minutes to 1 
hour. The latter would actually indicate moderate TBI. Thus, use of the fifth digit “2” as mild 
overestimates the number of persons with mild TBI and underestimates the number of persons with 
moderate TBI. 
Clinical Records Definition. Mild TBI is recognized when the medical records document any one of the 
following conditions: 
 Criteria consistent with the recommended conceptual case definition; 
 GCS score between 13 and 15 assigned at the time of first medical evaluation at a health-care 
facility; 
 Abbreviated Injury Severity Scale score of 2 for the head region (Gennarelli and Wodzin, 2008). 
Exclusions: Injuries accompanied by indicators of neurological deterioration during the course of acute 




Ascertaining the prevalence of disability attributable to severe TBI relies on medical records, access to 
supportive services,  and school or work status. Persons with severe TBI frequently have residual 
cognitive or other neurological disability (e.g., weakness, stiffness, slurred speech, incoordination, 
posttraumatic epilepsy) and commonly require long-term assistance. Patients with severe TBI who 
survive their injuries frequently require extensive rehabilitation, first as an inpatient and later as an 
outpatient. Neurological recovery might take place over months or even years; however, many do not 
recover to independent functioning or enter/re-enter the work place, and carry a diagnosis of chronic brain 
injury caused by trauma (Riggio, 2011). 
TBI-related disability is identified over time during the continuum of assessment and management of 
TBI. Ascertaining the prevalence of disability because of TBI is difficult for mild and moderate TBI. 
Patients with mild TBI can acquire conditions such as disordered sleep, fatigue, headache, dizziness, poor 
concentration, anxiety disorder, memory, and depressed mood. While recovery usually occurs during the 
first few months following injury, 10% – 50% might have symptoms that last more than a year (Riggio, 
2011). In addition, evidence suggests that persons with repeated events of TBI tend to recover more 
slowly after each ensuing event and in extreme cases might develop chronic neurodegenerative changes—
first seen as dementia pugilistica in boxers but now termed chronic traumatic encephalopathy (CTE) 
(McKee et al., 2010). 
Specialized survey techniques are necessary to quantify the incidence and duration of post-concussive 
syndrome. Batteries of standardized neuropsychological testing can determine the level of cognitive 
function in specific domains: attention, memory, executive function, processing speed, verbal ability, 
spatial ability, depressed mood, and symptom validity. However, pre-testing is not routinely done for 
most persons, making these comparisons challenging. Determining pre-injury levels of function is more 
difficult, but can be estimated based upon previous level of achievement in education or employment. 
Comparison of scores on pre-injury and post-injury tests of cognitive abilities might be the most reliable 
means to determine if the effects of TBI are persistent. 
Data Sources 
Civilian 
The primary responsibility for public health surveillance in the civilian system resides at the state level 
(Jacobson, Hoffman, and Lopez., 2007; Horan and Mallonee, 2003). Since the mid-1990s, CDC and at 
least 30 states have developed injury surveillance systems, including TBI (CDC State Programs, 2009); 
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the capacity of these state systems is variable (CDC unpublished data). States must improve their capacity 
to identify all injuries and yet have the specificity to identify TBI events and use linkages between data 
systems or other indicators to identify veterans with military service-related TBI in all 50 states and 
territories.  A number of civilian health and injury surveillance systems already exist and could 
incorporate additional measures to capture or validate information specific to TBI and/or military service 
(Table 5).   
Table 5. Civilian Public Health Surveillance Systems 
Name of Surveillance 
System  
(in alphabetical order) 
Agency Design and Use 
Behavioral Risk Factor 
Surveillance System 
(BRFSS) 
CDC and health departments 
in 50 states, District of 
Columbia, Puerto Rico, 
Guam, and Virgin Islands 
Population based, random-digit dialed telephone 
survey of adults (aged ≥18 years) in the United States; 
three components: core, optional, state-specific. Used 
to track health conditions, disability, and risk 
behaviors and to collect state/territory data on 
preventive health practices linked to chronic diseases, 
injuries, and preventable infectious diseases. 
CDC Traumatic Brain 
Injury Surveillance 
System (CDC TBI SS) 
CDC/National Center for 
Injury Prevention and 
Control: Core Violence and 
Injury Prevention Program 
(VIPP) 
Statewide representative ongoing population-based 
surveillance system. Used to identify, track, and 
analyze statewide trends in TBI. Information used to 
inform primary and secondary prevention strategies. 
National Ambulatory 
Medical Care Survey 
(NAMCS) 
CDC/National Center for 
Health Statistics 
Nationally representative multistage probability survey 
based on a sample of visits to non-federal office-based 
physicians engaged primarily in direct patient care. 
Excludes those in anesthesiology, radiology, and 
pathology. Representative sample used to identify and 
track ED and outpatient department visits. 
National Electronic 
Injury Surveillance 
System – All Injury 
Program (NEISS-AIP) 
Consumer Product Safety 
Commission (CPSC) and 
CDC/National Center for 
Injury Prevention and Control 
Nationally representative, stratified probability sample 
of all U.S. hospitals that have at least 6 beds and 
provide 24 hour ED services. Used to identify, track, 
and analyze national trends in injury-related ED visits.  
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National Health Interview 
Survey (NHIS) 
CDC/National Center for 
Health Statistics 
Population-based, nationally representative, face-to-
face probability sample survey among civilian, non-
institutionalized U.S. population. Used to monitor 
trends in illness and disability, track progress toward 
achieving national health objectives, characterize 
various health problems, determine barriers to access 








CDC/National Center for 
Health Statistics 
Nationally representative multistage probability 
sample of visits to emergency and outpatient 
departments and to ambulatory surgery facilities in 
noninstitutional general and short-stay hospitals, 
excluding Federal, military, and Veterans 
Administration hospitals, located in the 50 States and 
the District of Columbia. Used to identify and track 




CDC/National Center for 
Health Statistics 
Nationally representative three-stage stratified sample 
survey of inpatient hospital records acquired from 
probability sample of ~500 non-federal short-stay 
hospitals. Provides information on characteristics of 
patients of all ages that were hospitalized and 
discharged from hospitals in sample. 
Nationwide Inpatient 
Sample (NIS) 
Agency for Healthcare 
Research and Quality 
(AHRQ) 
Nationally representative multi-state health data 
system of all hospital discharges from a stratified 
probability sample of non-federal short-stay hospitals 
(40 states; 1,044 hospitals in 2007). Used to identify, 
track, and analyze national trends in health-care 
utilization access, charges, quality, and outcomes by 
diagnoses. 
State and Local Area 
Integrated Telephone 
Survey (SLAITS) 
CDC/National Center for 
Health Statistics 
Collection of broad-based ongoing surveillance 
systems; uses sampling frame of CDC's National 
Immunization Survey (NIS), following NIS random-
digit dialed telephone survey; surveys vary, based on 
need of sponsors. Tracks and monitors health and 
well-being of children and adults in 50 states, District 
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of Columbia, and 27 urban areas. Contacts more than 1 
million households annually. 
The National Health and 
Nutrition Examination 
Survey (NHANES) 
CDC/National Center for 
Health Statistics 
Nationally representative survey of 5,000 persons 
annually, combining interviews and physical exams; 
focus on different population groups or health topics. 
Used to determine prevalence of chronic conditions, 
risk factors for disease, nutritional status; helps to 
develop public health policy, direct and design health 
programs and services, and expand health knowledge. 
 
 
Department of Defense 
Armed Forces Health Surveillance Center (AFHSC) 
The Armed Forces Health Surveillance Center (AFHSC) was established in February 2008 by the DoD to 
be the central epidemiology health resource for the U. S. military.  It merges the capabilities and resources 
of the Army Medical Surveillance Activity (AMSA), the DoD Global Emerging Infections Surveillance 
and Response System (DoD-GEIS), and the Global Health Surveillance Activity of the Force Health 
Protection Directorate of the Office of the Assistant Secretary of Defense for Health Affairs. Also, 
AFHSC assumed responsibility for AMSA's Defense Medical Surveillance System (DMSS) and the DoD 
Serum Repository (DoDSR). DMSS contains up-to-date and historical data on diseases and medical 
events (e.g., hospitalizations, laboratory tests, immunizations) affecting SMs throughout their military 
careers. DMSS contains over two billion records on nine million service members and other beneficiaries 
of the MHS. 
The AFHSC maintains, promotes, and enhances the health of military and military-associated populations 
through development, refinement, and improvement of surveillance methods; coordinates a global 
program of militarily relevant infectious disease surveillance. 
Defense Medical Surveillance System (DMSS) 
In 1997, The Army Medical Surveillance System transitioned to the Defense Medical Surveillance 
System (DMSS).  This is the primary tool used by AFHSC for all its public health surveillance. It 
combines data from inpatient, outpatient, and purchase care databases maintained by TRICARE 
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Management Activity and contains personnel data from Defense Manpower Data Center and health 
assessments completed by SMs. The DMSS contains data from three main sources: Standard Ambulatory 
Record Data (SADR) and Comprehensive Ambulatory Professional Encounter Record (CAPER); 
Standard Inpatient Data Records (SIDR); and TRICARE Encounter Data (TED)/Health Care Service 
Record (HCSR). DMSS data are integrated in a continuously expanding longitudinal surveillance data 
base for all persons who have served since 1990 and facilitate the efficient analyses of morbidity among 
SMs. 
Theater Medical Data Store (TMDS) 
The TMDS receives data from various military and civilian systems, which allows the following: view 
clinical information; view, track, and manage ill or injured patients through continuum of care; access 
data on critically injured patients before they arrive a next point of care; access to deployment-specific 
medical data; access to blood inventory management activity; and, view pre-deployment health 
information.. 
Blast Tracker Program (BTP) 
The Army National Guard designed the Blast Tracker Program (BTP) as a secure data base accessible to 
all service branches via defense link website.  It will be incorporated into the Combined Information Data 
Network Exchange of U.S. Central Command data system. The goal is to capture blast and related events 
and identifies persons in proximity to blasts. Units and individual persons can receive reports and 
previously deployed units can add past exposure information. 
 
VA 
The following systems are implemented by the Veterans Health Administration (VHA) to identify 
veterans receiving health care within VA who have a possible TBI. 
VA TBI Screening and Evaluation Program 
The TBI Screening and Evaluation Program is a web-based tracking application that began in 2007 to 
capture information on veterans who screen positive for mild TBI using a TBI Clinical Reminder tracking 
system. The system was designed to improve screening for veterans of Operation Enduring Freedom 
(OEF) and Operation Iraqi Freedom (OIF) for mild TBI. The program provides information to confirm 
diagnosis and provide treatment.  
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VA TBI Health Registry 
The TBI Health Registry is a secure web-based portal for VA users to evaluate data, develop policies, 
assess resource demands, determine incidence/prevalence of TBI and evaluate treatment and outcomes. 
The system provides prospective longitudinal health surveillance, epidemiologic, and health-care quality 
analysis for OEF/OIF veterans. 
Challenges/Limitations 
The identification of veterans who had a military service-related TBI in the immediate or remote past in 
the civilian systems poses many medical, epidemiologic, methodologic, and administrative challenges. 
Collecting data, standardizing collection methods, and sharing data among partner agencies is a critical 
component of an overall plan to improve the outcome of TBI injuries. Furthermore, these data will 
support future efforts related to the implementation of prevention measures. 
Veterans with moderate or severe military service-related TBIs have the potential to be counted easily 
because their injuries are often self-evident. They frequently have clear clinical signs of brain injury or 
with imaging results (CT and/or MRI) that are abnormal. Similar to civilians, veterans with less severe 
TBIs might be more difficult to identify if their signs and symptoms were not evaluated immediately after 
the injury, not recorded (National Center for Injury Prevention and Control [NCIPC], 2003), or not 
diagnosed (Andary et al., 1997; Chambers, Cohen, Hemminger, Prall, and Nichols,1996). Long-term 
dysfunction might be related to multiple events of mild TBI, making the number of exposures as 
important as the severity of any single exposure. Accurate measures of the accumulated number of blast 
exposures add further complexity to accurate data gathering. Moreover, diagnosing TBIs that occurred 
years previously, such as during the First Gulf War, might be difficult because of substantial memory loss 
and inability to recall the initial diagnosis, external causes, or risk factors (Jekel, Katz and Elmore, 2001; 
Paterson and Scott-Findlay, 2002). Survivors also might have comorbidities, such as PTSD, that might 
mimic or overlap with the signs and symptoms of TBI (Glaesser, Neuner, Lutgehetmann, Schmidt, and 
Elbert, 2004; McMillan et al., 2001; Schneiderman, Braver, and Kang, 2008). In other instances, health-
care providers might not be able to detect or diagnose (Jekel, 2001) TBIs and/or determine causative 
factors, especially if they are mild (Andary et al., 1997; Chambers et al., 1996). Other medical concerns 
include malingering (Halligan, Bass, and Oakley, 2003; Sweet et al., 2000; Bianchini Curtis, and Greve, 
2006) or the inability of the civilian provider to access military medical records documenting the injury 
event, diagnosis and risk factors. 
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Identifying veterans who had a military service-related TBI since the beginning of the First Gulf War in 
the civilian system requires data sharing among interested parties. Such sharing of data might be 
particularly useful for identifying those veterans who are subsequently receiving care in the civilian 
health-care system. However, this poses administrative challenges, including the Health Insurance 
Portability and Accountability Act of 1995 (HIPAA) Privacy Rule (United States Department of Health 
and Human Services, 2009) that regulates uses and disclosures of “protected health information” (PHI) by 
covered entities (45 CFR 164). The HIPAA Privacy Rule defines covered entities as health-care 
providers, health plans, and health-care clearinghouses (45 CFR 160.103 (B)(3)). Examples of PHI 
include information that identifies or can be used to identify a person who is related to any physical or 
mental health condition, or treatment, or payment for treatment of a person by covered entities. 
The HIPAA Privacy Rule permits the disclosure of PHI without the authorization of the individual for 
specified purposes including disclosures required by law and disclosures to public health authorities who 
are authorized to collect it. HIPAA generally requires the disclosure of the minimum amount of 
information necessary to achieve the intended purpose (45 CFR 162.502 (b)).  CDC and state health 
departments, as public health agencies with public health authority, may obtain protected TBI-related 
health information for public health purposes (under 45 CRF 164.512(b)(2)) from VA and DoD to 
identify the target population of this report in the civilian system. Various applicable laws regulate the 
disclosure of identifiable information from CDC and state health departments (e.g., the Privacy Act, 
HIPAA Privacy Rule, state laws).  Development and dissemination of veterans’ TBI-related information 
in the civilian health-care and public health systems will require high levels of cooperation and 
collaboration among various federal (CDC, NIH, DoD, and VA), state, local entities, and other 
stakeholders. Despite these hurdles, the Federal TBI Common Data Elements project is developing 
standards so that TBI in persons formerly in the military is effectively measured and data shared among 
interested parties while maintaining appropriate privacy protections. The ongoing activities of this 
interagency group can go a long way towards further strengthening collaboration and data sharing among 




Epidemiology is the study of the distribution and determinants of health-related states or events in 
specified populations, and the application of this study to the control of health problems (Last, 1988). 
The epidemiology of a condition, like TBI, can be characterized using data collected via surveillance 
systems as described in the surveillance section above. Injury surveillance data are useful for several 
reasons. Even the simplest surveillance programs are designed to identify as many persons as possible 
who have a particular injury or disease. Other programs, like the CDC Core Violence and Injury 
Prevention Program surveillance system (Marr and Coronado, 2004), might collect additional data about 
selected demographic and clinical characteristics of the injured population, cause of injury, alcohol use, 
and use of protective devices, such as seat belts or motorcycle helmets.  
Although surveillance systems typically do not collect data at the same level of detail as research studies, 
they provide more current data than research data. Furthermore, they can generate data on an ongoing 
basis, which is useful for studying, for example, trends or the efficacy of preventive interventions 
(Coronado et al., 2009). Obtaining more detailed epidemiologic data requires in-depth and time-
consuming studies of specifically defined populations (Coronado et al., 2009). In most cases, researchers 
find it feasible to collect the necessary amount of details from samples of persons drawn from a 
population of interest rather than study the entire population (Coronado et al., 2009). These limitations 
contribute to the difficulty of extrapolating results from detailed studies to surveillance data. However, 
data from both approaches are necessary to understand the magnitude and effects of injuries and diseases. 
Incidence: Traumatic Brain Injury 
Incidence indicates the number of new cases that occur over time. It is usually expressed as a percentage 
of persons who will be affected during a year, or as a rate calculated as the number of persons who 
develop the condition during a period divided by the number of person-years at risk. 
From 2000 through 2011, a total of 235,046 service members (SMs) (4.2%) of the total 5,603,720 who 
served in all components of the Army, Air Force, Navy, and Marine Corps were diagnosed with a TBI. 
Most of these SMs with a TBI (76.7%) had a mild TBI (Figure 1). Less than 3% of SMs with a TBI had 
severe and penetrating TBIs (Figure 1). 
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Figure 1. Percentage of U.S. Military Service Members Diagnosed with a TBI, by TBI 
Severity, 2000-2011 (N=235,046) 
 
Source: Defense and Veterans Brain Injury Center 
The overall rate of TBI among active duty service members more than doubled from 720.3 per 100,000 
SMs to 1,811.4 per 100,000 SMs from 2000 to 2011 (Table 6 and Figure 2). The TBI rate increased 
dramatically from 2006 to 2008 followed by slight increases in 2010 and 2011. This may reflect an actual 
increase in TBI, but may also reflect an increased number of SMs deployed along with increased 
awareness of the need to seek care and improved recognition and diagnosis. Overall TBI rates increased 
in every active-duty service branch from 2000 through 2011 (Figure 3). The largest increases were among 
active-duty Army and Marine Corps members. The rate of TBI in the active-duty Army was 3.3 times 
higher in 2011 than in 2000 (2,717.9 versus 815.6 per 100,000 service members). The TBI rate among 
active-duty Marine Corps personnel in 2011 was 2.4 times higher than in 2000 (2,286.3 versus 959.8 per 
100,000 SMs). 
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Table 6. Estimated Annual Rates* of TBI among Active-Duty U.S. Military Service 
Members by TBI Severity, 2000-2011. 
Year Penetrating Severe Moderate Mild 
Not 
Classifiable† Overall 
2000 17.9 11.6 274.8 413.7 2.3 720.3 
2001 19.4 12.6 234.4 506.0 2.3 774.7 
2002 13.9 9.2 192.3 553.7 2.4 771.5 
2003 16.0 10.4 150.1 563.5 1.8 741.8 
2004 17.1 9.0 128.5 614.7 2.1 771.4 
2005 13.9 9.8 108.3 581.5 2.3 715.9 
2006 19.7 11.1 145.3 835.7 3.4 1015.1 
2007 23.9 13.3 216.9 1087.5 13.8 1355.3 
2008 27.7 15.1 193.6 1289.5 169.7 1695.6 
2009 28.2 18.5 205.0 1279.8 126.6 1658.1 
2010 17.1 13.3 236.8 1405.6 90.7 1763.6 
2011 15.8 12.3 239.4 1429.1 114.8 1811.4 
*Incidence Rates per 100,000 service members. 
†Changes were made to the DoD TBI case definition in 2008 to include codes that do not provide 
information about the severity of the TBI. 
Source: Defense and Veterans Brain Injury Center. 
The mild TBI rate among active-duty service members increased from 2000 through 2011 (Table 6 and 
Figure 4). The increase in the rate of mild TBIs accounted for most of the increase in the overall TBI rate 
in the active-duty military population. The rate of moderate TBIs in this population decreased from 2000 
through 2005 and then increased in 2006 and 2007, followed by a decrease in 2008 and then increased 
each year through 2011 (Table 6 and Figure 4). The rates of penetrating and severe TBIs among active-
duty service members increased dramatically from 2006 through 2009 (Table 6 and Figure 5). However, 
these rates decreased substantially after 2009 (Table 6 and Figure 5). In 2010 and 2011, the rate of 
penetrating TBIs among active-duty service members decreased 43.9%. During those 2 years, the rate of 
severe TBIs decreased 33.4%; this decrease is likely a function of multiple factors including fewer people 
deployed and improvements to both vehicles and personal protective equipment. 
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Figure 2. Estimated Overall Annual Incidence Rates of TBI Among Active-Duty U.S. 
Military Service Members, 2000–2011 Surveillance Systems 
 
Source: Defense and Veterans Brain Injury Center 
 
Figure 3. Estimated Overall Annual incidence Rates of TBI among Active-Duty U.S. 
Military Service Members by Service Branch, 2000–2011 
 
Source: Defense and Veterans Brain Injury Center 
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Figure 4. Estimated Annual Incidence Rates of Mild and Moderate TBIs and TBIs with 
Unclassifiable Severity Among Active-Duty U.S. Military Service Members, 2000–2011 
Source: Defense and Veterans Brain Injury Center 
 
Figure 5. Estimated Annual Incidence Rates of Penetrating and Severe TBIs Among 
Active-Duty U.S. Military Service Members, 2000–2011 
 
Source: Defense and Veterans Brain Injury Center 
. 
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The incidence of blast-induced TBI in U.S. civilian populations is low, with a report of 0.2% of TBI cases 
in a major urban trauma center (Bochicchio et al., 2008); however, civilian blast injuries are becoming an 
increasing problem worldwide (Summers et al., 2009). Data for TBI in the civilian population from 1995 
to 2009 show that the rate for emergency department visits increased significantly from 434.1 per 100,000 
population in 1995 to 686.0 per 100,000 in 2009.  During the late 1990s, the rate of TBI hospitalizations 
decreased significantly from 95.5 per 100,000 population in 1995 to 77.9 per 100,000 in 2000 but then the 
rate increased over subsequent years and the rate for 2009 was similar to that reported in 1995.  Deaths in 
which a TBI was listed either as an isolated injury or in conjunction with other injuries decreased 
significantly from 19.9 per 100,000 in 1995 to 16.6 per 100,000 in 2009 (Coronado et al., 2012).  
Although additional research is required to understand the specific causes, a number of factors may have 
contributed to the significant increase in the rate of TBI-related emergency department visits including the 
increased awareness of head injury through education campaigns (for example, CDC’s Heads Up: 
Concussion campaign), the efforts of various sports organizations to reduce TBI among athletes, and the 
media attention given to TBI among military service members fighting in Iraq and Afghanistan.  In 
addition, a number of states have passed legislation to reduce TBI in youth sports, further raising 
awareness of the importance of addressing these kinds of injuries among coaches, athletic trainers, 
parents, and youth.  While a number of factors likely contributed to the decline in TBI-related deaths, the 
largest single contributor is the reduction in the number of transportation related deaths (Coronado et al, 
2012).  
Prevalence: Traumatic Brain Injury 
Prevalence is the number of all new and old cases of a disease or occurrences of an event (in this case 
TBI) during a particular period (Mosby 2009).  
Active Duty Military Personnel 
Determining the prevalence of TBI in the transient military population remains challenging as it might not 
allow accounting for all those who are living with the consequences of this condition. Other challenges 
stem from the use of multiple databases and electronic medical records that lead to duplication of cases or 
inability to locate records and inconsistencies in coding that might contribute to inappropriate symptom 
attribution. 
Another concern that can affect reporting prevalent cases is the lack of chronic TBI codes. Commonly, 
SMs might be seen and treated for persistent headaches following TBI. The primary diagnostic code is 
captured as headache. Unless a history of TBI code is also used, this person might not be captured in 
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reporting. The DoD, CDC, VA, and other federal agencies collaborated to revise the ICD-9 codes that 
most accurately reflect TBI. These revisions that are already in use incorporated consideration of co-
morbid conditions and were publicly reviewed, discussed, and adapted by all partners. The addition of 
cognitive-behavior codes is important because many of the symptoms of mild TBI overlap with 
psychological comorbidities, in particular PTSD. 
Inconsistencies in coding also might affect reporting. To overcome these problems, educational activities 
are underway to ensure that providers and medical coders consistently use recommended codes that will 
enhance incidence and prevalence detection. Guidance documents have been developed to assist in 
improving documentation (TRICARE 2010; Defense Centers of Excellence, 2010). 
To better estimate the prevalence of TBI in the military, MHS requires continuing the practice of 
conducting pre-deployment screening to have baseline measures; after a possible TBI, screening all SMs 
as soon as possible; training all medical personnel in the detection of TBI and coding methods for TBIs; 
improving and maintaining better medical record keeping and reporting; and expediting the 
standardization of the multiple and disparate databases in the military. Efforts have been initiated to 
coordinate databases within the DoD and other federal agencies as mandated by the National Defense 
Authorization Act (NDAA). 
The majority of TBIs are mild (approximately 80%; Thurman, Alverson, Dunn, Guerrero, Sniezek, 1999; 
Defense and Veterans Brain Injury Center, unpublished data) and less likely to yield chronic symptoms. 
If mild TBI-related symptoms are present, they are often non-specific headaches, dizziness, or cognitive 
or neuropsychiatric difficulties. According to current coding guidelines, chronic symptoms, such as 
headache, are recorded but often without information necessary to determine whether and how they may 
be attributed to a prior TBI. Therefore, the prevalence of mild TBI is difficult to ascertain. SMs who have 
sustained a moderate, severe, or penetrating TBI and who are represented in the TBI database are more 
likely to have disability linked to their TBI. However, with the exception of post-traumatic epilepsy, no 
process is in place for determining and recording long-term consequences. 
Veteran Population 
The overall U.S. veteran population is diverse and includes those who served during various eras, 
including WWII, the Korean conflict, the Vietnam War, the First Gulf War, OEF/OIF, and other conflicts 
and operations. The number of women veterans has steadily increased; beginning in the First Gulf War, 
women have played an increasingly important role in the U.S. military. Estimating the TBI prevalence in 
veteran population should optimally consider services provided by both the VA health-care system and 
civilian medical facilities outside of that system. Prevalence among OEF/OIF veterans seen by VA is 
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defined by data from VA’s Inpatient (PTF) and Outpatient (OPC) treatment records data and is presented 
in Table 7. 
Table 7. Numbers of OEF/OIF Veterans Reported with ICD-9-CM Codes Indicative of TBI 
Diagnosis or a Selected TBI Outcome or Other Type of Head Injury Commonly 
Associated with TBI who were Evaluated or Treated in the VA Health-Care System from 











Fracture of base of skull
2
 113 
Fracture of face bones
2
 3,237 
Other and unqualified skull fracture
2
 90 






Cerebral laceration and contusion
3 
 392 
Subarachnoid, subdural, and extradural hemorrhage following injury
3 
 243 
Other and unspecified intracranial hemorrhage following injury
3 
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Intracranial injury of other and unspecified nature
3 
 18,509 




The sum of the number of veterans corresponding to each ICD-9-CM code is more than 59,218 because a 
patient might have more than one ICD-9-CM code. 
2
ICD-9-CM codes that are commonly associated with TBI. 
3
ICD-9-CM codes with specific TBI diagnoses. 
Source: Epidemiology Program, Post Deployment Health Group, Office of Public Health, Veterans 
Health Administration, Department of Veterans Affairs, March 2012.  
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Epidemiologic studies of the long-term consequences of TBI, including those that focused on veterans 
who served during WWII, the Korean conflict, and the Vietnam War have been reviewed by the Institute 
of Medicine (IOM 2009). Many of the early studies of TBI reviewed by IOM focused on moderate or 
severe TBI or pre-date contemporary improvements in assessment, treatment, and rehabilitation, 
highlighting the ongoing need for additional research. 
Several factors have contributed to current interest in understanding the epidemiology, early detection, 
treatment, and rehabilitation of not only moderate and severe TBI but also mild TBI. This includes 
increased use by enemy forces of improvised explosive devices (IEDs) and rocket propelled grenades 
(RPGs); increased survival of military service men and women who are critically injured on the 
battlefield; and recognition of the potential for overlap between mild TBI and PTSD. In the last decade 
studies within the U.S. military and VA systems have addressed the long-term consequences of military 
service-related TBI. Of these studies, most address the consequences of military service-related mild TBI 
(Hoge et al., 2008; Schneiderman et al., 2008, Taber and Hurley 2009; Rona et al, 2012).  
The National Defense Authorization Act of Fiscal Year 2008 (Public Law 110-181, Section 1704 (d) 
requires the VA Secretary to establish and maintain a TBI Veterans Health Registry (VHR). The registry 
must include information about each person who served as a member of the Armed Forces in OEF/OIF 
who exhibits symptoms associated with TBI and who applies for services or files a disability claim. 
Section 1704 also stipulates that the VA shall collaborate with facilities that conduct research on 
rehabilitation for persons with TBI, facilities that receive grants for such research from the National 
Institute on Disability and Rehabilitation Research (NIDRR), DVBIC, and other relevant programs of the 
Federal government, including the Defense Centers of Excellence. 
Pursuant to this statutory requirement, VA sought an interagency agreement with NIDRR through which 
VA can draw upon the expertise of NIDRR's TBI Model Systems (TBIMS) program—the largest 
longitudinal database for TBI in the country. With NIDRR’s assistance, VA is working to develop a TBI 
VHR housed on secure web-based portal at the TBIMS National Data and Statistical Center in Denver, 
Colorado. The portal will be accessible to authorized VA users and developed in compliance with VA 
data security regulations, HIPAA, and Privacy Act considerations. A custom-built web portal will enable 
authorized VA users to access data to support policy development and evaluation; assess resource usage 
and health-care needs; determine incidence and prevalence of TBI among OEF/OIF veterans; and 
evaluate course of treatment and outcomes. 
Characterizing the prevalence and long-term consequences of military service-related TBI in the civilian 
system will require even greater manpower and economic resources to ensure that appropriate linkages 
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are made between the military, VA, and civilian health care systems. There is also an absence of fully 
valid and reliable screening instruments to diagnose TBI, especially cases of mild TBI, and the co-
occurrence of cases of PTSD and TBI that are not correctly classified. Moreover, the natural history of 
combat-related TBI, especially its long-term consequences, has not yet been fully explained (Ramchand 
et al., 2008). 
Because the VA system provides medical care to a subset of all eligible veterans, conducting studies of 
the prevalence of military service-related TBI will likely require the use of civilian databases, for 
example, the TBIMS or the Framingham Study. The Framingham Study has been conducting research on 
neurological disorders for decades. In 1997, for example, it began a post-mortem Brain Tissue Donation 
Program that has enrolled more than 600 participants and analyzed approximately 100 brains—yielding 
substantial information on genetics, the environment, the aging process, stroke, Alzheimer's disease, 
Parkinson's disease, or other neurological illness. Because the program can also document the extent of a 
disease, military service-related TBI and civilian TBI could also be studied. 
Civilian Population 
Certain challenges related to TBI prevalence in military-associated cases also affect civilian populations. 
An estimated 3.2 million Americans are living with long-term consequences from TBI (Zaloshnja, Miller, 
Langlois, and Selassie, 2008). This estimate reflects the use of updated methodology and is based on the 
results of statistical modeling and analysis of 2005 TBI hospitalization incidence data from Maryland, 
Vermont, and New Jersey. A previous CDC estimate indicated that approximately 2% (approximately 5 
million) of the U.S. population live with the long-term consequences of TBI (CDC, 1999). These 
estimates, likely underestimate the prevalence of TBI-related disability as they do not include persons 
with TBI who were treated and released from emergency departments or other health-care settings, those 
who were treated in a DoD or VA facility, or who did not seek treatment. With current resources and 
limitations in surveillance methodology, the prevalence of TBI-related impairment and disability in the 
United States cannot be measured with confidence (Coronado et al., 2009). 
Interview surveys that attempt to link history of TBI to a disability are prone to underreporting, mainly 
because of poor or no recall of past injuries (Walker, Logan, Leukefeld, and Stevenson, 2004). Population-
based prospective cohort studies of persons recently diagnosed with an acute TBI might be more 
promising. Using this method, two studies examined the occurrence of TBI-related disability in 
representative samples of persons followed 1 or more years after hospitalization for TBI (Whiteneck et al., 
2004; Pickelsimer et al., 2007). Since information on annual disability (Selassie et al., 2008) does not 
account for the cumulative prevalence of TBI, statistical methods must be applied to estimate such figures 
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(Zaloshnja et al., 2008). The true prevalence of military and civilian TBI and TBI-related disability in the 
general U.S. population will remain elusive without continued investment in sound, long-term, 
representative follow-up studies or adding questions into existing national surveys, such as, NHIS, 
NHANES, and SLAITS. 
The Economic Costs of TBI 
The economic costs of TBI are difficult to estimate in both the military and civilian populations. Some of 
the reasons include 1) uncertainty about which outcomes can be attributed specifically to TBI, 2) 
variability in the types of TBI-related outcomes, 3) inability to measure the precision of cost estimates, 
and 4) limited resources (including data available for research) to conduct more complex and long-term 
economic studies. Some estimates are more straightforward whereas others can only be derived using a 
large number of assumptions and complicated econometric and statistical methods that distance the 
estimates from actual cost data (Coronado et al., 2009). 
Because of these difficulties, few attempts to estimate the costs of TBI have been undertaken, especially 
those costs faced by society as a whole. One recent study estimated the annual economic burden of TBI in 
the United States in year 2000, including direct medical and rehabilitation costs and societal costs, to be 
$60 billion (Finkelstein, Corso, and Miller, 2006). The few studies that have attempted to estimate the 
cost of TBI injury among military SMs have had major limitations such as including only hospitalized 
cases of TBI and studies with small sample sizes. Despite these limitations, available data suggest that the 
total costs might be substantial (Ommaya, Ommaya, Dannenberg, and Salazar, 1996; Wallsten and 
Kosec, 2005; Eibner, Ringel, Kilmer, Pacula, and Diaz, 2008). 
Certain studies have attempted to estimate the costs of TBIs that have resulted from OEF/OIF. One study 
estimated that the total lifetime cost of severe TBIs sustained in OIF through August 2005 to be $16 
billion (Wallsten and Kosec, 2005), but it has two limitations that must be considered. First, the authors 
estimated that 20% of all SMs wounded in OIF had a severe TBI, which is high when compared with 
DoD data. DoD TBI surveillance data indicate that only 1% of all SMs with a TBI during that time 
sustained a severe TBI (Defense and Veterans Brain Injury Center, unpublished data). Furthermore, the 
estimated proportion was obtained from a newspaper article rather than actual surveillance data. The 
second limitation was that the lifetime cost of severe TBI was based on numerous assumptions and 
estimated costs that might not be applicable to SMs with TBI. For example, the data used to estimate 
lifetime-treatment costs was derived from civilian sources and might not be applicable to the DoD and 
VA health systems. A 1996 study of costs for acute treatment of TBI among SMs and their beneficiaries 
suggests that costs in military hospitals might be lower than costs in private hospitals (Ommaya, 1996). 
 65 
Furthermore, a highly variable and controversial cost, known as the value of a statistical life (VSL), was 
used to estimate other aspects of the lifetime cost of severe TBI, such as lost wages. The VSL is the value 
that a person places on a marginal change in their likelihood of death; it is estimated by looking at the 
risks that people are voluntarily willing to take and how much they must be paid for taking them (Viscusi 
and Aldy, 2003).  A review of literature about VSL indicated that it can vary from $4 million to $9 
million per life, depending on the assumptions made and methodology used to estimate it (Viscusi and 
Aldy, 2003). 
In 2008 the RAND Corporation released a report estimating TBI costs resulting from OEF/OIF (Eibner et 
al., 2008). The report provided cost estimates for acute treatment and rehabilitation, mortality and suicide, 
and lost income. In the first year following injury, costs were estimated to be $27,260 to $32,760 per case 
for mild TBI and up to $408,520 for those with moderate to severe injury. The estimated overall cost for 
acute treatment of deployment-related TBIs in the hospital in 2005 ranged from $6.9 million to $14.3 
million. The estimated cost of inpatient rehabilitation was $1.9 million and the estimated cost of 
outpatient rehabilitation ranged from $377,000 to $907,000. The estimated costs associated with mortality 
from deployment-related TBIs in 2005 ranged from $67 million to $89 million, unemployment associated 
with deployment-related TBI was $13 million, and reduced wages associated with deployment-related 
TBI was $1.2 million.  
These estimates have the same serious limitations as those calculated by Wallsten and Kosec in 2005. 
Treatment cost estimates are derived from civilian cost data that might be different from costs incurred by 
military hospitals. In addition, estimated costs resulting from the death of a SM are based on the VSL, 
which can vary substantially. Another serious limitation is that the estimated treatment cost per case of 
mild TBI in the RAND report is for SMs who required hospitalization. This estimate is likely too high for 
most SMs with a TBI because most persons with mild TBI only are not hospitalized. More problematic is 
the lack of evidence regarding the extent of long-term disability resulting from blast exposure and 
whether other major health effects such as neurodegenerative disorders might arise years later. 
Using 1992 data, the Defense and Veterans Head Injury Program, now DVBIC, published estimates of 
TBI-related costs in the military (Ommaya et al., 1996). These costs were estimated from a study of 5,568 
SMs and other beneficiaries of the MHS who were hospitalized for TBI in both military and private 
hospitals in FY 1992. The authors attempted to compare costs from both types of hospitals. Although 
outdated, these estimates are the only ones known to be published that were derived from actual costs 
incurred by the MHS. The overall estimated cost of TBI-related hospitalizations in the U.S. military 
medical system in 1992 was approximately $42 million (Ommaya, 1996). 
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Current military per-patient hospitalization costs associated with TBI in the military can be estimated by 
adjusting Ommaya et al.’s estimates for inflation. This method has been used by others to update older 
cost estimates (Thurman, 2001). Table 8 presents Ommaya et al.’s per patient cost estimates adjusted to 
2011 dollars. However, these estimates have limited reliability because the inflation factor used for 
adjustment was not just for hospitalizations, and included all types of health care. Furthermore, the 
inflation rate for TBI treatment costs might be different from treatment cost inflation for other conditions. 
Table 8. Estimated Median Acute Hospitalization Cost per Patient for Military Personnel 




TBI Characteristics Military Hospital Private Hospital 
TBI with no LOC* $1,773 $5,308 
TBI with any LOC* $2,299 $8,216 
TBI with LOC of unknown duration $2,901 $6,051 
TBI with LOC >1 hour $8,237 $22,744 
TBI with other type of injury $10,245 $10,991 
TBI with other health condition $3,967 $7,835 
* LOC=loss of consciousness. 
† Costs presented in this table are medians of actual costs incurred by military hospitals and allowable 
expenses paid by the MHS to private hospitals in fiscal year 1992 (Ommaya et al.1996). These costs 
have been adjusted to 2011 dollars using the U.S. city average CPI for medical care (US Bureau of 
Labor Statistics). Military and private hospital cost estimates might not be directly comparable because 
of the different methods used to compute them. However, the military hospital costs include the clinic 
proportion of total facility expenses including construction, maintenance, staff wages, equipment, and 
supplies. 
Source: Defense and Veterans Brain Injury Center.
 
 67 
Estimating the Cost of TBI 
The only way to obtain realistic estimates of TBI-related costs in the military is to perform a 
comprehensive long-term study that obtains actual cost data at the level of individual patients, based on 
specific TBI characteristics, treatments, comorbidities, health consequences, rehabilitation needs and 
long-term disability. Such a study must follow injured SMs and veterans over a long period to collect 
accurate cost data for services they receive. It must also account for the effects of improvements in 
technology and treatment on costs to ensure compatibility of cost estimates from different periods. To 
obtain information about the economic consequences of TBI-related mortality, families of those SMs who 
died from TBIs also can provide insight. Without continued study of the outcomes of military service-
related TBI, estimates of the total costs of TBI to society will continue to rely mostly on assumptions and 




Many potential ways exist to prevent TBI and the poor outcomes that can result when TBIs are sustained. 
Improving outcomes from TBI includes pre-hospital care and faster transport to medical centers. Early 
detection with better diagnostic tools also can lead to better outcomes when paired with timely 
interventions. Reducing risk of injury and preventing further damage after initial injury are essential to 
ensuring improved outcomes. Protective gear, including helmets, can prevent or reduce the severity of 
TBI. Helmet use is recommended in many sports and combat situations, and improved helmets with 
stronger and lighter weight ballistic materials for the helmet’s outer shell as well as new helmet pads to 
provide greater blunt impact protection are under development as part of a developmental program known 
as the Soldier Protection System (SPS).   
The goal of SPS is to do development and testing during FY13 and FY14 with the intention of beginning 
production in FY15. The use of seatbelts in motor vehicles is required, as are motorcycle helmets for SMs 
in the non-deployed setting. Although not yet well understood, chest protection also seems to reduce blast 
TBI severity in rats, possibly by preventing systemic changes in blood pressure (Long et al., 2009). 
Enhanced forms of hard armor ballistic plates, improved outer tactical vests, pelvic protection systems, 
ballistic eyewear, and limited numbers of face shields and lower mandible protectors have already been 
fielded and will be further enhanced through the SPS.  All of these improvements to personal protective 
gear are crucial advances for SMs moving outside of the forward operating bases and especially when 
dismounted from a vehicle. In addition, improved vehicle armor has also been instituted over the last 
several years to mitigate blast effects on vehicle occupants. Improvements in protective eyewear not only 
minimize fragment penetration to the eyes but also penetration to the brain. 
Among veterans and SMs returning to the United States who are no longer at risk for deployment-related 
injuries, the prevention of TBI is similar to the civilian population (Figure 6). The majority of TBIs, either 
occurring alone or in conjunction to other injuries, are caused by several factors (e.g., falls, motor vehicle 
traffic crashes, and striking or being struck by an object or person, or acts of violence against oneself and 
others) (Faul et al., 2010). 
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Figure 6. Fatal and Nonfatal Traumatic Brain Injuries either occurring alone or in 
conjunction with other injuries by Mechanism - US, 2002-2006.  
 
Source: Faul M, Xu L, Wald MM, Coronado VG, 2010. 
 Preventing TBI Associated with Motor Vehicle Traffic 
Crashes 
Motor vehicle crashes and resulting injuries are a serious public health problem among civilian and 
military populations. Implementing prevention strategies to decrease the occurrence of these incidents is a 
public health priority. 
Mortality rates from severe TBI in motor vehicle crashes (a leading cause of severe TBI in civilians and 
SMs) have declined since the 1970’s, but remain unacceptably high. Programs and policies that encourage 
improvements in vehicle design, the road environment, and reductions in risky behaviors such as 
speeding, alcohol-impaired and distracted driving can reduce the risk of crashes. Activities that encourage 
improvements in occupant protection such as appropriate seat belt use and air bags can reduce the risk of 
injury in the event of a crash. Programs and policies to protect motorcyclists from injury include those 
that promote the use of helmets. Risks to pedestrians can be reduced through various measures that 

















Preventing TBI Associated with Falls 
Causes of falls vary, whether they occur as a result of falls among adults who might slip in their homes or 
teenagers who fall while engaging in athletic activities. Among older adults, fall-related injuries can be 
reduced by programs supporting regular weight-bearing and balance exercises; over the counter and 
prescription medication review to reduce use of those causing dizziness or drowsiness; annual eye exams 
to optimize vision; and home modifications when prescribed by an occupational therapist (e.g., reducing 
tripping hazards, adding grab bars inside and outside the tub or shower and next to the toilet, adding stair 
railings and improving lighting) (Stevens, 2010; Gillespie et.al., 2009). Injuries from falls among 
working-aged adults are most commonly experienced on the same level, on/from stairs or steps, or from a 
height such as on ladders or scaffolds; fall injuries during work are similar to those that are non-work 
related, suggesting that programs and policies successful in one arena might be applicable to others 
(Smith, Sorock, Wellman, Courtney, and Pransky, 2006). 
Preventing TBI Caused by Striking or Being Struck 
Struck by/against events are those in which a person was struck and unintentionally injured by another 
person or object (e.g., falling debris, a ball in sports) or a person struck against an object, such as a person 
struck against a wall or a collision between two or more people (Rutland-Brown et. al., 2006). Many 
sports-related TBIs are included in this category. Sports and recreation-related TBIs can be prevented by 
programs and policies encouraging appropriate use of safety gear (such as helmets), environmental 
changes (such as padding goal posts and padding or removing other obstacles), strict officiating and 
enforcement of rules and sportsmanship, and examination of effects of select rule changes (Gilchrist, 
Saluja, and Marshall, 2007). 
Rest before returning to play or work after even mild TBI is equally important. Re-injury leading to 
sudden death (second-impact syndrome) has been reported in some athletes who returned to sports after 
symptomatic concussions (Franklin, 2012). As described in the In-theater Screening section under 
Diagnosis, the military has implemented required rest periods following TBI. 
Preventing TBI Associated with Intentional Injury 
In addition to assaults, TBIs can result from self-directed violence, which is included as “other/unknown” 
in Figure 6. Interpersonal conflicts, relationship problems, and alcohol/drug use are common 
circumstances preceding homicides and suicides (Karch, Logan, and Patel, 2011). Suicide and violence- 
prevention strategies can reduce the risk of TBI by enhancing social problem solving and coping skills, 
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improving access and reducing barriers to appropriate mental health care, and providing support and 
services to those struggling with multiple life stresses, including financial, substance abuse, and family 
violence-related challenges (Lubell and Vetter, 2006; Goldsmith, Pellmar, Kleinman, and Bunney, 2002; 
CSPV, 2012). In addition to individual and family-level factors, suicide and violence prevention strategies 
also need to address community-level factors such as norms about violence and help-seeking, access to 
education and employment opportunities, and the level of connectedness or social bonds among people 
(CDC, 2010). 
Prevention of Secondary Brain Injury 
Improved Emergency Medical Services (EMS) or pre-hospital care has substantially improved outcomes 
from TBI. In the prevention of secondary brain injury, pre-hospital care focuses on keeping airways open, 
maintaining blood and oxygen flow to the brain, and controlling blood pressure and hemorrhage, which 
can all improve survival and reduce long-term damage. Implementation of other types of early 
interventions to prevent secondary damage (e.g., hypothermia and administering osmotic agents) might 
depend on the situation, nearby infrastructure, and availability of experienced emergency teams (Boer et 
al, 2012). 
Biomarkers for diagnosis also have the potential to improve early intervention and prevention of 
secondary injury. Research to identify TBI biomarkers is ongoing (Schiff, 2012; Papa, 2012). Some gene 
variants might have positive or negative effects on TBI outcomes (Dardiotis et al., 2010; Miller et al., 
2010; Al Nimer et al., 2012; Darrah et al., 2012). 
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IX. Recommendations 
CDC, NIH, DoD and VA acknowledge that the military service-related TBI cases will be difficult to 
identify in civilian systems because several of these cases occurred in the past (e.g., during the early years 
of OIF). However, the majority of the incident and prevalent cases of military service-related TBI can be 
identified through TBI screening and reporting conducted by DoD and VA. Identifying cases of TBI not 
diagnosed while in service or by the VA system, although more difficult, might be possible by conducting 
surveys on veteran status; by educating health-care providers to ask their patients with TBI-related signs 
and symptoms about previous military service and risk factors, and to use, when appropriate, the terrorism 
and war-related ICD-9-CM external cause of injury (E) codes. 
To accomplish the mandates of the TBI Act of 2008 and to address identified public health concerns, 
CDC, NIH, DoD, and VA produced general recommendations applicable to all federal agencies and 
departments. In addition, recommendations specific to each agency and department might be useful for 
guiding their interactions with stakeholders. Underlying these recommendations is a commitment to using 
data sources that are accessible, valid, and reliable. 
General Recommendations 
CDC, NIH, DoD, and VA concur on the following key recommendations: 
 STRENGTHEN COLLABORATION:  Continue to foster and strengthen collaboration related 
to identifying military service-related TBI among current military SMs and veterans, including 
those who do not seek care from the military or VA health-care systems. Improving data 
collection and sources will be emphasized. 
 UTILIZE STANDARD DEFINITIONS: Improve reporting through federal agencies that use 
and promote standard clinical and surveillance definitions and severity classification of TBI 
among U.S. military and civilian health-care providers and researchers. 
 ENHANCE CODING AND CLASSIFICATION:  Continue to foster and strengthen 
collaboration with each other and other relevant organizations on coding and classification of 
TBI. All four participating agencies should continue to meet with professional, academic, health 
care, and coding organizations to discuss improvements in ICD-10-CM, including the 
classification of TBI and concussion and differentiation of self-limited and persistent symptoms. 
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Revise the intracranial injury code set in ICD-10-CM to improve the accuracy of disease coding 
consistent with accepted case definitions before ICD-10-CM implementation on October 1, 2014. 
 IMPROVE DISSEMINATION: Promote dissemination of information by federal agencies to 
non-VA facilities regarding TBI services available through the VA health-care system since 
2007, including baseline screening and follow-up assessment and evaluation. 
 BUILD EVIDENCE BASE:  Continue research on the neurological consequences of blast 
events and TBI among SMs and veterans; the research should include 1) systematic 
neuropathological study in blast-exposed SM’s and veterans who have died; 2) correlation of 
neuropathological and brain imaging findings; 3) prospective investigation of whether blast 
exposure increases risk for subsequent cognitive decline and neurodegenerative diseases such as 
chronic traumatic encephalopathy, Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis. 
Recommendations to Improve TBI Diagnosis and Treatment 
Military Health System 
Development and validation of helmet-mounted sensor systems (HMSS). The Vice Chief of Staff of 
the Army (VCSA) directed that soldier combat helmets be fitted with electronic sensors that can record 
helmet response to dynamic events (blunt impacts, ballistic impacts, and/or exposure to blast events). 
Sensors that could be able to predict when someone has reached a threshold for exposures are under 
development (McAllister et al., 2012; Broglio, Surma, and Ashton-Miller, 2012). Development of a signal 
library of carefully controlled blunt, ballistic, and blast signatures will allow indirect identification of 
mechanical insults (exposure) of HMSS signals from the field. This will allow the development of an 
injury assessment tool, as the first approximation of a dose-response curve. Expanding the use of these 
sensors to the USMC and others with these types of exposures will be based on the efficacy of the Army’s 
initial use of them. 
Development of therapeutics to improve the outcome of mild, moderate, and severe TBI. Despite 
advances in basic and clinical research and neurological intensive care in recent years, and despite 
promising pre-clinical data, most of the clinical trials have failed to yield any significant improvement in 
TBI outcome. Nevertheless, DoD is currently exploring combination drug therapies, novel drugs, and 
small-volume resuscitation liquids (i.e., fluids administered to patients in relatively small amounts to 
restore and maintain adequate blood circulation following severe blood loss) for their ability to improve 
functional recovery from TBI. 
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Development of animal/computer model for TBI, most importantly for blast TBI. No validated 
animal model exists for blast TBI. Development of a clinically and physiologically relevant model is 
critical for the successful validation of helmet-mounted sensors, SMs’ protective armor, and for the 
evaluation of therapeutic interventions. Through a collaboration among Joint Improvised Explosive 
Device Defeat Organization (JIEDDO), DVBIC, and the Institute of Soldier Nanotechnology at MIT, the 
most advanced computer model of the brain and blast effects on the brain has been developed (Moore et 
al., 2009). Work to determine characteristic pathology of human blast injury is underway. 
Identification of biomarker(s) to identify mild TBI/assay to discriminate between mild TBI and 
PTSD. Distinguishing between mild TBI and PTSD is complicated because of partial overlap in 
symptoms, including irritability, memory  and concentration difficulties. The development of rapid, non-
invasive, reliable testing is needed to discriminate between the subtle cognitive deficits of mild TBI and 
PTSD. Serum  biomarkers such as S-100 protein show promise, although utility has been limited by its 
short half-life. Other biomarkers, including lactate dehydrogenase, neuron specific enolase, also might be 
useful but lack sensitivity and specificity (Ingebrigtsen and Romner, 2002; Pike et al., 2004; Ringger et 
al., 2004; Pineda et al., 2007; Papa et al., 2010). Preliminary results from ongoing serum biomarker 
studies are more promising. If these injuries could be detected objectively, quickly, and non-invasively, 
medical personnel would be able to begin early interventions. 
VA Health System 
The VA Office of Research and Development sponsored a State of the Art Conference in 2009 to identify 
research priorities for TBI. Representatives from DoD, NIH, DVBIC, and VA attended. A planning 
committee commissioned background papers for workgroup discussions. The papers examined topics 
such as the pathology of blast-related brain injury; diagnosis; comorbidities, including mental health 
issues and sensory deficits; brain imaging; care management; community reintegration; and, the role of 
veterans’ families in TBI care. Six work groups focused on different aspects of TBI (i.e., basic science, 
neuroimaging, sensory deficits, comorbidities, rehabilitation and community reintegration, and care 
management) and then presented summaries of their findings and research recommendations for 
discussion with the entire group.  An issue of the Journal of Rehabilitation and Development was 
dedicated to this meeting (Volume 46, Issue 6) and the research recommendations of the work groups 
were grouped into three main categories: (1) Diagnosing TBI (e.g., screening and imaging), (2) 
understanding short- and long-term effects of TBI (e.g., co-occurring conditions, severity, 
neurodegenerative disease), (3) understanding existing treatment approaches and developing new 
treatments (e.g., neurotrophins, neuroplasticity, case-management, community re-integration). 
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Civilian Health System 
Although many opportunities exist to advance opportunities for TBI research and improve diagnosis and 
treatment in the civilian health system—that is, the organization of people, institutions, and resources to 
deliver health care services for the general population, a few strategic future directions for the field, with 
leadership from CDC, NIH, DoD, and the VA, include the following: 
Developing a pathoanatomical classification system for TBI. During the past two decades much has 
been learned about TBI at a cellular and molecular level. Applying this knowledge to develop effective 
therapies for specific subtypes of injury, rather than for the entire constellation of injuries, is likely the 
key to developing successful interventions. Characterizing the pathophysiology and temporal evolution of 
these subtypes of injury would provide a foundation for identifying therapeutic targets and the window of 
opportunity for using them. It would provide the necessary scientific rationale for testing single and 
combined agents to hit these targets to attenuate injury or promote repair processes. A new classification 
system based on the pathoanatomy, rather than on the Glasgow Coma Scale also would inform chemical 
biomarker development and correlation of pathology with neuroimaging for these subtypes of injury. 
Surrogate markers would make it possible to identify people who have these subtypes of injury and also 
to monitor the biological effects of experimental interventions during clinical trials. Overall, breaking 
down the complex problem that TBI presents into smaller, more manageable parts should make it a more 
tractable problem. 
Discovering the biological basis of mild TBI. This builds upon the previous recommendation because 
the milder injuries are often less complex than more severe injuries. Current research should be further 
enhanced to identify the biological mechanisms responsible for persistent deficits such as PCS and 
concurrent conditions including PTSD and to develop diagnostic tools for persons currently classified as 
having a mild TBI. Because a subset of persons described as having a mild TBI experience persistent 
disabilities, the term “mild” is often misleading. 
Developing more effective and efficient approaches for preclinical drug development. 
Approximately 130 agents with proven preclinical efficacy for TBI are available, and more are under 
development and testing (Marklund, Bakshi, Castelbuono, Conte, and McIntosh, 2006). An efficient 
testing system for optimizing the dose and timing and for comparing effectiveness of interventions, alone 
and in combination, is needed to accelerate therapy development. 
Facilitating data sharing. To date, much of the research on TBI has been small studies across agencies 
and centers, without definitively answering important research questions. A federal interagency project 
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developed standardized terminology and a data dictionary for TBI to enable data sharing and secondary 
analysis and meta-analysis. In addition, the Federal Interagency TBI Research Informatics, a DoD and 
NIH collaboration, is available for aggregating and sharing data. Use across federal agencies is 
encouraged. Ongoing and new research on biomarkers would be accelerated by sharing data and 
supporting larger, multicenter projects to rapidly obtain greater numbers of samples and subjects. This is 
also true for advancing the development of neuroimaging and other diagnostic tools and biomarkers and 
for the validation of outcome measurement tools for clinical trials. 
Coordinating and collaborating on clinical studies for TBI. A large, prospective observational 
comparative effectiveness research study is an efficient way to address some of the major gaps in 
knowledge regarding the validity of diagnostic tools and biomarkers and the effectiveness of various 
medical and surgical interventions for TBI. A coordinated and collaborative effort would enhance trial 
designs, increase the rate of subject enrollment and data collection, and optimize statistical analysis and 
data interpretation. Studies would be completed more quickly, and if successful, this collaborative 
approach would also facilitate implementation of these valid diagnostic tools, biomarkers,  and proven 
interventions into clinical practice. TBI clinical studies should include subjects across the spectrum of 
injury severity, across the lifespan, during acute and chronic stages of injury, and should evaluate 
pharmacologic and non-pharmacologic interventions. 
Methodological Concerns and Research Priorities 
Evidence indicates that continued research is needed to 1) determine the magnitude and socioeconomic 
and medical impact of military service-related TBI; 2) identify preventable and modifiable risk factors to 
reduce injury; 3) reduce impairment and disability; and 4) develop and evaluate evidence-based 
interventions. 
CDC, NIH, DoD, and VA recommend that studies of the incidence and prevalence of military service-
related TBI must include the following: 
 Designed with clear and relevant research questions and methodology; 
 Involve statistically representative populations; 
 Allow determination of risk factors and the socioeconomic and demographic characteristics of 
these populations; and 
 Allow characterization of the acute and long-term outcomes for TBI. 
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Such studies could assist in developing primary, secondary, or tertiary prevention programs, especially if 
modifiable risk factors are identified. Moreover, prevalence studies have the potential to identify gaps and 
guide resource allocation. 
CDC, NIH, DoD, and VA also recommend continued evaluation and improvement of screening tools for 
TBI, especially tools used to identify milder forms of TBI. These studies are important to assess the 
incidence, prevalence, and long-term consequences of TBI, and the availability of and access to TBI-
related support and rehabilitation services. 
Finally, the four agencies also recognize that the recommendations in this report and all TBI-related 
management and treatment guidelines used by CDC, NIH, DoD, and VA need to be updated every 3 to 5 
years to incorporate findings of epidemiologic, clinical, social, and behavioral research. The agencies are 
already working together through the Common Data Elements project and this provides one useful forum 
for regular reviews of important issues. 
Morbidity and mortality associated with TBI affect civilian, military, and veteran populations. The 
leading causes of these injuries vary according to age and sex of injured persons. Therefore, these 
recommendations, prepared by the four participating agencies, will ensure that present practices in 
diagnosis of TBI and treatment for those persons affected by it will be sustained and improved. 
Additional progress to improve structural changes in defining TBI, improving surveillance systems, and 
recording epidemiologic data will assist in forming an achievable plan for the future. 
Recommendations to Improve TBI Surveillance 
Military Health System 
To better estimate the incidence and prevalence of TBI in the MHS, DoD recommends: 
 Screening all SMs as soon as possible following a possible TBI-causing event,  
 Using the MACE or other appropriate screening tools; and  
 Training all medical personnel (from theater through the VA system) in the detection and correct 
coding of TBI.  
 Improving record keeping and standardizing multiple and disparate databases in the U.S. military 
using standardized common, streamlined questionnaires with variable complexity, depending on 
the level of care provided by the reporting medical facility (e.g., uncomplicated questionnaires for 
medics in theater to complex questionnaires for tertiary care facilities.) Coordination of databases 
has been initiated among DoD, VA, and NIDRR model systems. 
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Veterans Health System 
Recommendations to better estimate the incidence and prevalence of TBI in the VA include:  
 Continue screening all OEF/ OIF veterans upon contact with the VA health system;  
 Training of all medical personnel in the detection of TBI and in the methods to correctly code for 
TBI; and, 
 Timely and comprehensive follow-up evaluation of all veterans who screen positive for possible 
TBI. 
Civilian Health System 
Recommendations to improve surveillance of TBI in the civilian health system include: 
 Expand surveillance activities by ensuring that TBI surveillance is part of comprehensive state 
injury surveillance systems, 
 Continue to collaborate with DoD and VA to identify strategies for improving surveillance of TBI 
among veterans. 
Methods for Detecting TBI Incidence and Prevalence 
Military Health System 
Key areas have been identified to improve measuring the incidence and prevalence of TBI in the military 
system, including case ascertainment; case documentation and reporting; follow-up; and, data 
dissemination.  Specifically: 
 Continue to use the established guidelines and strategies for identifying and treating TBI as 
described in this report; evaluate and update such guidelines every 3 years to reflect the advances 
in methods and technology. 
 Produce portable data collection instruments to capture TBI data in the military, the VA, and 
civilian systems. These instruments should be specific to the level of care (e.g., a standard 
instrument to be used in theater only). 
 Use TBI-specific diagnostic and external cause ICD-10 and ICD-9-CM codes to identify new 
cases (incidence) and history codes to ensure capturing prevalence data, recognizing the 
challenges of current coding and classification of TBI. 
 Expand current care coordination and case management programs within DoD and VA to 
facilitate follow-up care and to document patients with persistent symptoms. 
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 Coordinate and exchange aggregated-level data (excluding personal identifiers) with 
CDC/NCIPC to produce a yearly report on TBI in the military by race/ethnicity, sex, age group, 
and risk factors. This report also should include information on the clinical characteristics, 
comorbidities, and concurrent injuries in persons with acute and chronic TBI. 
VA Health System 
Key areas have been identified to improve measuring the incidence and prevalence of TBI in the VA 
including:  
 VA health-care system facilities should screen for TBI among eligible OEF/OIF veterans upon 
contact with the VA health system and further evaluate those who screen positive.  
 Timely and comprehensive follow-up evaluation should be offered to veterans who screen 
positive for possible TBI.  
 Medical personnel should be trained in TBI and in the methods to correctly code for TBI, 
recognizing the challenges with regard to current coding and classification of TBI. 
Civilian Health System 
Key areas have been identified to improve measuring the incidence and prevalence of TBI in the civilian 
health system including: 
 Enhance capabilities to conduct surveillance at the state level; using national surveys, including 
public and private telephone and internet-based systems; and encouraging civilian and military 
health-care providers to document and report war and terrorism-related external cause-of- injury 
codes (E-codes). 
 For all federally funded TBI research, use the newly recommended common operational clinical 
and surveillance definitions described earlier in this report, including all TBI-related ICD-10 and 
ICD-9-CM diagnostic, external cause of injury, terrorism, and war-related codes. 
 Reporting incident cases of military service-related TBI while SMs are in the military. 
Collaborate with DoD, VA, and Defense Medical Surveillance System to share aggregated level 
data via CDC, and through peer and non-peer reviewed publications, periodicals, mass media, 
and books. Aggregate DoD TBI surveillance data is currently available at 
http://www.dvbic.org/dod-worldwide-numbers-tbi.  
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 Identification, surveillance, and burden of cases of military service-related TBI in veterans 
seeking care outside the VA system, which might include those who have not sought medical care 
or were not diagnosed while SMs in the military or VA health-care systems.  
 Initiate research that examines disability, quality of life, and long-term outcomes associated with 
all severity levels of TBI. 
 Add questions to federal or state sponsored population-based follow-up studies to determine the 
occurrence and the epidemiologic and clinical characteristics of the long-term consequences of 
TBI among eligible persons. 
 Use existing civilian and military-related TBI surveillance systems and registries to develop 
prospective follow-up studies to determine the long-term epidemiologic, clinical, cognitive, and 
socioeconomic characteristics among eligible persons; and to determine if these persons have 
access to and receive appropriate social and rehabilitation services. 
 Share TBI systems and registries available in the civilian, DoD, and VA Health Systems to 
determine the occurrence and the long-term medical and socioeconomic characteristics of TBI 
among eligible persons. 
 Assess the burden of military service-related TBI in veterans receiving care outside the VA 
system. Routinely use the recommended federal TBI definitions when analyzing data from large 
national surveys and surveillance systems conducted by CDC/NCHS and other federal agencies 
(see Data Sources in Chapter VI). 
 
Recommendations to Improve TBI Prevention 
Ultimately the goal is to prevent the occurrence of TBI for SMs on- and off-duty. During off-duty hours 
and those retired from active duty, the risks are similar to the civilian population, with falls and motor-
vehicle crashes among the major causes. Active-duty SMs face additional risk from blast and penetrating 
injuries. Further research is needed to ensure these risks are reduced. Where evidence-based strategies 
exist, it is imperative that there is strict adherence to those practices. The recommendations below focus 
on continued research to reduce risk factors, improve the quality of protective equipment, and ensure that 
current guidelines and evidence-based strategies are adhered. 
 Enhance research to reduce the risk of TBI from blast injury. 
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 Research to promote adherence to current guidelines on returning to active-duty following TBI. 
 Conduct more research to improve the quality of protective equipment such as helmets. 
 Strengthen evidence on the risk and protective factors associated with a TBI or the prevention of 
a TBI. Research may include but is not limited to reducing use of alcohol, ensuring adherence to 
use of seatbelts, motorcycle helmets and other protective equipment. 
 Provide meaningful education to veterans who have sustained a TBI, their families and their 
clinicians about the elevated risk for subsequent TBI and actions that can be undertaken to 
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